System and method for radiotherapy planning

By using relaxation values ​​to adjust the target in the generation of radiation therapy plans, the time-consuming and complex generation of the generation process is solved, faster and more accurate treatment plans are achieved, and the automation capabilities of the system are improved.

CN118925083APending Publication Date: 2024-11-12ELEKTA AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410577602.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-05-11
Filing Date
2024-05-10
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The generation process of radiation therapy plans is time-consuming and complex, especially when multiple treatment plan goals exist, making it difficult to quickly and accurately generate plans that meet all goals.

Method used

By receiving the reference target, the optimization process is performed to determine the parameter set, and the target is adjusted using a slack value when the implementation value does not meet the target, thereby determining the configuration of the radiation therapy system, improving the speed and accuracy of the plan generation.

Benefits of technology

Reduces the time and manual input required for treatment plan generation, improves the accuracy and automation of the plan, and enhances the possibility of convergence of subsequent steps.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118925083A_ABST
    Figure CN118925083A_ABST
Patent Text Reader

Abstract

A method for implementing a radiation therapy plan for radiation therapy by a radiation therapy system, the method comprising: receiving a reference target representing a target to be implemented by the radiation therapy system; performing an optimization process according to the received reference target to determine a parameter set relating to a characteristic of radiation to be delivered by the radiotherapy system, where the optimization process comprises: optimizing the parameter set to obtain an implementation value; and obtaining a slack target using the implementation value and the slack value in response to the implementation value not satisfying the reference target; and determining a configuration of the radiotherapy system using the optimized set of parameters and the relaxation target.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] Embodiments herein relate to systems and methods for delivering radiation therapy planning for radiation therapy. Background Art

[0002] Radiation therapy or radiotherapy can be described as the use of ionizing radiation to damage or destroy unhealthy cells in humans and animals. Ionizing radiation can be directed to tumors on the surface of the skin or deep inside the body. Common forms of ionizing radiation include X-rays and charged particles. An example of a radiation therapy technique is the Gamma Knife. ) or Leksell Gamma ), where a patient is irradiated with multiple lower intensity gamma rays that are focused at a target area (e.g., a tumor) with higher intensity and precision. Another example of radiation therapy includes the use of a linear accelerator (linac), whereby a target area is irradiated with high energy particles (e.g., electrons, high energy photons, etc.). In another example, radiation therapy is provided using heavy charged particle accelerators (e.g., protons, carbon ions, etc.).

[0003] The placement and dose of radiation beams are accurately controlled to provide a prescribed radiation dose to a target area (e.g., a tumor) and reduce damage to surrounding healthy tissue (referred to as organs at risk or OARs). One aspect of treatment planning involves determining the appropriate characteristics of the radiation to be delivered to produce a safe and effective dose. The characteristics of the radiation involve, for example, a fluence pattern. The fluence pattern can depend on the beam arrangement, energy, and field size, which in turn are related to controllable parameters (which are optimizable). By determining appropriate values ​​for these parameters, a suitable fluence pattern can be obtained. The treatment plan can be determined by a treatment planning system.

[0004] Radiation therapy planning (treatment planning) involves using an optimization process to determine the optimal set of parameters that will deliver an appropriate dose. The optimization process can be based on clinical and dosimetric goals and constraints. Examples of clinical and dosimetric goals and constraints include maximum, minimum, and mean doses to tumors and critical organs. Clinical and dosimetric goals and constraints can be referred to as treatment plan objectives.

[0005] The treatment planning process can include using a three-dimensional image of the patient to identify the target area and identify critical organs near the tumor. Segmentation can be used to identify the target area, the area to be treated (e.g., planned target volume (PTV)), and the organ at risk (OAR). After segmentation, a dose plan can be created for the patient, which indicates the desired amount of radiation to be received by the PTV (e.g., target) and / or OAR. The PTV can have an irregular volume.

[0006] In a practical example, there may be multiple anatomical structures (i.e., PTV, target, and / or OAR). For example, in head and neck treatment, there may be more than 20 anatomical structures. For each structure, it is desired to meet various treatment plan goals. Different priorities can be assigned to the structures and their goals in order to achieve a clinically acceptable plan. Determining a treatment plan that meets the various goals is time consuming and complex.

[0007] There is a need for improved methods and systems for generating treatment plans. Summary of the invention

[0008] As described above, the generation of treatment plans can be time consuming and complex, especially when there are many treatment planning goals.

[0009] Treatment planning includes performing an optimization process that optimizes multiple parameters with the goal of providing a sufficiently high dose to the PTV while reducing the dose to surrounding healthy tissue. A clinically appropriate plan can be obtained by balancing different treatment planning goals, for example, by prioritizing treatment planning goals related to dose coverage at the PTV and then prioritizing treatment planning goals related to protecting OARs. By prioritizing one goal over another, it means performing an optimization process based on a first goal and then performing another optimization process based on a second goal having a lower priority than the first goal. It should be understood that throughout this process, optimization and its variations can be used interchangeably.

[0010] A user (e.g., a treatment planner, dosimetrist, clinician, or healthcare worker) can implement a clinically appropriate plan as follows. For each treatment plan objective, the user can configure the optimizer by defining, for example, a reference dose, a reference volume, and / or a cost function. An example of a treatment plan objective can be stated as "97% of the PTV volume should receive at least 40 Gy." This objective represents the goal to be achieved. The optimizer will then attempt to find the optimization parameters that meet the goal. The solution found by the optimizer may or may not meet the desired goal (based on the anatomical structure, the limitations of the radiotherapy machine, and / or the difficulty of the problem). Based on the achieved goal, the optimization can be repeated using the revised goal to be achieved. This method is time-consuming and results in variable results based on the user's selection of the revised goal to be achieved. In addition, when multiple treatment plan objectives are considered, the method is repeated for each objective, making plan generation more time-consuming.

[0011] The inventors of the present invention have designed methods and systems that can improve the quality of generated treatment plans and reduce the time required to generate such plans. These methods and systems also reduce the need for user input. In particular, the inventors have designed methods and systems whereby, for each treatment plan goal, an optimization process is performed to obtain an implementation solution (implementation value). Based on whether the implementation solution meets the treatment plan goal (reference goal), a relaxed goal (using a relaxation value) is obtained and then used in subsequent steps. The relaxed goal is not as strict as the treatment plan goal and / or the implementation solution. The relaxed goal provides an improved starting point for subsequent steps. The relaxed goal increases the possibility of convergence in subsequent steps or the possibility of obtaining appropriate results in subsequent steps.

[0012] The method and system herein solve a technical problem that arises in the field of radiation therapy planning, namely, how to improve the generation of treatment plans. The method can improve the accuracy of the generated treatment plans and the speed of generation. The method also automates the generation of treatment plans.

[0013] According to one aspect, a method for radiation therapy planning for performing radiation therapy by a radiation therapy system is provided, the method comprising:

[0014] receiving a reference target, the reference target representing a target to be achieved by the radiation therapy system;

[0015] performing an optimization process to determine a set of parameters based on the received reference target, the set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system, wherein performing the optimization process comprises:

[0016] Optimize the parameter set to obtain the achieved value;

[0017] In response to the achieved value not satisfying the reference target, obtaining a relaxed target using the achieved value and the relaxed value; and

[0018] The configuration of the radiation therapy system is determined using the optimized parameter set along with the relaxation target.

[0019] The configuration of the radiation therapy system may be output for delivery of radiation by the radiation therapy system.

[0020] Executing the optimization process may include performing a first-pass optimization, the first-pass optimization including: optimizing a parameter set to obtain a first-pass realized value, and in response to the first-pass realized value not satisfying a reference target, using the first-pass realized value and the first-pass relaxed value to obtain a first-pass relaxed target, and determining a configuration of the radiotherapy system using the optimized parameter set and the first-pass relaxed target.

[0021] The method improves the generation of a treatment plan by performing an optimization (first pass optimization) to obtain a first solution (first pass achieved value) and, in response to the first solution not meeting a desired target (reference target), using the achieved solution (first pass achieved value) and the relaxation value (first pass relaxation) to obtain a relaxed solution (first pass relaxed target). Then, the configuration of the radiotherapy system is determined using the optimized parameters and the relaxed solution (first pass relaxed target).

[0022] The relaxation values ​​(first relaxation values) are used to modify the achieved solution (first pass achieved value) to obtain a relaxed solution (first pass relaxation target). The relaxed solution is then used to determine the configuration of the radiotherapy system without requiring additional input from the user. The purpose of using the relaxation values ​​to modify the achieved solution is to allow "room" for subsequent steps and / or to allow access to a wider solution space in subsequent steps. This improves the performance of the method (e.g., by increasing the likelihood that the determined configuration is acceptable) and improves the chances of generating a treatment plan without requiring additional user input.

[0023] A realization solution involves a quantity that is comparable to a reference target (eg, it has the same units and / or meaning).

[0024] Based on the optimized parameter set and the relaxed solution, a configuration of the radiotherapy system is determined. For example, the configuration may involve the arrangement of field modifiers. The determined configuration may be used by the radiotherapy system to perform radiotherapy.

[0025] In one embodiment, the method includes:

[0026] In response to the first pass achieving values ​​satisfying the reference target, a configuration of the radiation therapy system is determined using the optimized set of parameters and the reference target.

[0027] When the achieved value meets the reference target, the reference target is used in subsequent steps. No relaxation is applied. By using the reference target instead of the achieved value (which meets or outperforms the reference target), more space is allowed for subsequent steps.

[0028] In one embodiment, determining a configuration of a radiation therapy system using an optimized set of parameters and a first pass relaxation target includes:

[0029] Perform the optimization process using the first-pass relaxed objective as the goal or constraint.

[0030] In one embodiment, the method further comprises:

[0031] Performing a second pass of optimization, wherein performing the second pass of optimization includes:

[0032] In response to the first-pass achieved values ​​satisfying the reference target, further optimizing the parameter set according to the received reference target so that the radiation therapy system achieves a second-pass achieved value; and

[0033] Obtaining a second-pass relaxation target using the second-pass realization value and the second-pass relaxation value; and

[0034] The configuration of the radiation therapy system is determined using the further optimized parameter sets and a second pass of the relaxed objectives.

[0035] When the first pass achieved value meets the reference target, no relaxation is applied in the first pass optimization. A second pass optimization is performed, and by further optimizing the parameter set, a more suitable solution is obtained. By obtaining the second pass relaxed target for determining the configuration, a wider solution space can be accessed in the determine configuration step. By further optimizing the parameter set in the second pass optimization, it means that the solution from the first pass (e.g., optimized parameters) is used as a starting point.

[0036] In one embodiment, determining the configuration of the radiation therapy system using the further optimized set of parameters and the second pass relaxed objective includes performing a further optimization process using the second relaxed treatment planning objective as a goal or constraint.

[0037] In one embodiment, the parameter set relates to a fluence pattern of radiation to be delivered.

[0038] In one embodiment, the set of parameters comprises weights for the beamlets.

[0039] In one embodiment, determining the configuration of the radiation therapy system includes determining a placement of a beam shaping device.

[0040] In one embodiment, the beam shaping device is a multi-leaf collimator (MLC).

[0041] In one embodiment, the first pass relaxation value and / or the second pass relaxation value are automatically set according to the cost function. This enables the first / second pass relaxation value to be set according to the cost function used in the optimization. For example, some cost functions may converge more slowly than other cost functions. This can improve the speed of optimization and the suitability of the achieved values.

[0042] In one embodiment, the reference target includes any of a cost function, a reference dose, and / or a reference volume.

[0043] In one embodiment, when the reference target comprises a reference dose, the cost function comprises any of the following functions: a maximum dose cost function, an average dose cost function, a continuous cost function, and / or an equivalent uniform dose (EUD) cost function.

[0044] In one embodiment, when the reference target comprises a reference volume, the cost function comprises any of the following functions: a dose volume histogram (DVH) based cost function, a target penalty cost function, or a parallel cost function.

[0045] In one embodiment, the reference target relates to any one or more of the following targets: region of interest, shell, planning target volume (PTV), critical structure, and organ at risk.

[0046] In one embodiment, the first pass relaxation value is obtained relative to the first pass realization value and is further bounded by a lower limit value and an upper limit value. This enables the first pass relaxation target to have a more appropriate value, adapted to the type of reference target, and further improves the optimization.

[0047] In one embodiment, the second relaxation value is less than the first relaxation value. This further improves the optimization process. In the first pass, the optimizer already covers a wide solution space by being constrained by the larger first relaxation value. Using the smaller second relaxation value in the second pass narrows the solution space and leads to improved optimization.

[0048] In one embodiment, the second relaxation value is between 25% and 75% of the first relaxation value. This is to further ensure that the second goal achieved by the treatment planning system is within an acceptable range.

[0049] According to one example, a method for delivering radiation therapy by a radiation therapy system is provided, the method comprising:

[0050] receiving a first reference target and a second reference target, each reference target representing a target to be achieved by the radiation therapy system;

[0051] For each reference target, sequentially optimizing the parameter sets according to any of the foregoing methods; and

[0052] The configuration of the radiation therapy system is determined using the sequentially optimized parameter sets and the first reference target and the second reference target.

[0053] According to another aspect, there is provided a method for radiation therapy planning for radiation therapy by a radiation therapy system, the method comprising:

[0054] receiving a first reference target and a second reference target, each reference target representing a target to be achieved by the radiation therapy system;

[0055] Performing a first optimization pass to determine a set of parameters according to the first reference target and the second reference target, the set of parameters relating to characteristics of radiation to be delivered by the radiation therapy system, wherein performing the first optimization pass comprises:

[0056] Optimizing the parameter set based on the first reference target so that the radiation therapy system achieves a first pass realization value;

[0057] In response to the first pass realization value not satisfying the first reference target:

[0058] Obtaining a first-pass relaxation target using the first-pass realization value and the first-pass relaxation value; and

[0059] optimizing the set of parameters based on the second reference objective and using the first-pass relaxed objective as a constraint so that the radiation therapy system achieves an additional first-pass achieved value;

[0060] A second optimization pass is performed according to the first reference target and the second reference target to determine a further optimized parameter set, which

[0061] , performing the second pass of optimization includes:

[0062] Responsive to the additional first-pass realization value satisfying the second reference target:

[0063] optimizing the parameter set based on the second reference target so that the radiation therapy system achieves an additional second-pass achieved value;

[0064] as well as

[0065] obtaining additional second-pass relaxation targets using additional second-pass achieved values ​​and second-pass relaxation values; and determining a configuration of the radiation therapy system using at least the further optimized parameter set, the first-pass relaxation target, and the additional second-pass relaxation target.

[0066] According to another aspect, there is provided a method for delivering radiation therapy by a radiation therapy system, the method comprising:

[0067] receiving a first reference target and a second reference target, each reference target representing a target to be achieved by the radiation therapy system;

[0068] Performing a first optimization pass to determine a set of parameters according to the first reference target and the second reference target, the set of parameters relating to characteristics of radiation to be delivered by the radiation therapy system, wherein performing the first optimization pass comprises:

[0069] Optimizing the parameter set based on the first reference target so that the radiation therapy system achieves a first pass realization value;

[0070] Responsive to the first pass achieving that the value satisfies the first reference goal:

[0071] optimizing the parameter set based on the second reference target using the first reference target as a constraint so that the radiation therapy system achieves an additional first-pass achieved value;

[0072] A second optimization pass is performed according to the first reference target and the second reference target to determine a further optimized parameter set, wherein:

[0073] Performing the second pass of optimization involves:

[0074] Responsive to the first pass achieving that the value satisfies the first reference goal:

[0075] Optimizing the parameter set based on the first reference target so that the radiation therapy system achieves a second pass achieved value; and

[0076] Obtaining a second-pass relaxation target using the second-pass realization value and the second-pass relaxation value; and

[0077] A configuration of the radiation therapy system is determined using at least the further optimized parameter set and a second pass of the relaxed objectives.

[0078] According to another aspect, there is provided a treatment planning system for implementing radiation therapy by a radiation therapy apparatus, the treatment planning system comprising a processor configured to:

[0079] receiving a reference target, the reference target representing a target to be achieved by the radiation therapy system;

[0080] Performing a first optimization pass to determine a set of parameters based on the received reference target, the set of parameters relating to characteristics of radiation to be delivered by the radiation therapy system, wherein performing the first optimization pass comprises:

[0081] Optimizing the parameter set so that the radiotherapy system achieves the first pass achieved value;

[0082] In response to the first-pass realized value not satisfying the reference target, obtaining a first-pass relaxed target using the first-pass realized value and the first-pass relaxed value;

[0083] The configuration of the radiation therapy system is determined using the optimized parameter set and the first pass relaxation target.

[0084] In an embodiment, the treatment planning system comprises a processor configured to perform any of the methods described above.

[0085] According to another aspect, there is provided a computer-readable medium comprising computer-executable instructions configured to cause a processor to perform any of the above methods.

[0086] In an embodiment, the method is a method for radiation therapy planning for delivering radiation therapy by a radiation therapy system.

[0087] In some examples, a configuration of a radiation therapy system may be output for delivery of radiation by the radiation therapy system.

[0088] The methods are computer-implemented methods. Since some methods according to the examples may be implemented by software, some examples encompass computer code provided to a general purpose computer on any suitable carrier medium. The carrier medium may include any storage medium (e.g., a floppy disk, CD ROM, magnetic device, or programmable storage device) or any transient medium (e.g., any signal, such as an electrical, optical, or microwave signal). The carrier medium may include a non-transient computer-readable storage medium. BRIEF DESCRIPTION OF THE DRAWINGS

[0089] Systems and methods according to non-limiting examples will now be described with reference to the accompanying drawings, in which:

[0090] Figure 1A A block diagram of an optimization process according to an example is shown;

[0091] Figure 1B A block diagram of an optimization process applied to IMRT according to an example is shown;

[0092] Figure 2 A flow chart showing a method of radiation therapy planning according to an embodiment;

[0093] Figure 3 A flow chart showing a method of radiation therapy planning according to an embodiment;

[0094] Figure 4 A flow chart showing a method of radiation therapy planning according to an embodiment;

[0095] Figure 5 A first part of a flowchart showing a method of radiation therapy planning according to an embodiment;

[0096] Figure 6 Shows Figure 4 The second part of the method of radiation therapy planning is shown;

[0097] Figure 7 A schematic diagram of a computing device according to an embodiment is shown;

[0098] Figure 8 A schematic diagram showing a computer readable medium according to an embodiment; and

[0099] Fig. 9 A radiation therapy device or apparatus is shown. DETAILED DESCRIPTION

[0100] Figure 1A A block diagram of an optimization process 100 is shown. The optimization process 100 is applicable to the optimization of a parameter set (i.e., one or more parameters) of a radiation therapy system. The one or more parameters may be referred to as optimizable parameters or decision variables. Examples of optimizable parameters include parameters related to characteristics of radiation to be delivered by the radiation therapy system. For example, the parameter set relates to a flux map. The flux map may also be referred to as an intensity distribution map. The flux map may correspond to weights for beamlets (beamlets are described below). An example of a radiation therapy system will be described below.

[0101] The optimization module 100 includes an optimizer 107. Given a model 101 and one or more parameters 103, the purpose of the optimizer 107 is to provide an optimized set of parameters 111 to minimize the cost function 102. The optimizer includes at least one optimization algorithm, such as a simplex algorithm, a gradient-based algorithm, an interior point algorithm, and the like, and combinations thereof. Other optimization algorithms are also possible. The optimization algorithm may be executed until a stopping criterion is reached. For example, the stopping condition may be any one or more of the following conditions: reaching the number of iterations, satisfying the convergence criteria, and violating a constraint (such as the constraint 105 described herein). The constraint may be a predetermined constraint defined before performing the optimization process. Examples of predetermined constraints are the clinical and planning constraints shown in rows a to l of Table 1. Alternatively, the constraints may be obtained from a previous optimization process. An example of optimization is The optimization process may correspond to the optimization process described in European patent application publication EP3681600A1, for example.

[0102] The model 101 is a representation of the physical problem. For radiation therapy planning, the model 101 includes, for example, a dose distribution over voxels in a region. The dose distribution can be the dose at a unit integral flux. The region can correspond to an anatomical structure. The anatomical structure can include one or more of the following structures: a target, a healthy tissue region (called an organ at risk or OAR), a planning target volume (PTV), a critical structure, or a shell structure. These structures are determined and / or defined during a process called segmentation. Shell structures are structures that are generated to adjust the dose delivered to tissue surrounding the target, and they can be used to control dose conformality. The dose distribution can be determined by a pencil beam algorithm, a convolution-based algorithm, and / or a Monte Carlo (MC)-based algorithm. Additional details on how the dose can be determined are described in The training guide (Document ID: LTGMON0530 (Elekta AB)) is provided.

[0103] The one or more parameters 103 are optimizable parameters (also referred to as decision variables) for which the optimizer 107 attempts to find optimal values. The one or more parameters 103 may be initialized to predetermined values. In one example, for IMRT, when the parameters 103 are weights of beamlets, the parameters 103 may be initialized to predetermined weights. Alternatively, the parameters 103 may be initialized to values ​​determined in a previous step. For example, when performing further optimization, the parameters may be initialized to values ​​determined in a previous optimization.

[0104] The beam can be divided into beamlets, where the weight of each beamlet can be adjusted. A beam can be understood as a beamlet matrix. Therefore, a beam can be represented by a number of beamlets. The total dose distribution is then the weighted sum of the contributions of the individual beamlets at unit flux (e.g., the dose at voxel k is given by ∑x n ·d n,k Given, where n is the index of beamlet n, x n is the weight of beamlet n, and d n,k is the dose at unit flux at voxel k due to beamlet n). By adjusting the weights of the beamlets, the radiation can be modulated. The weights of the beamlets can be adjusted by adjusting the configuration of the beam shaping device (e.g. Figure 8 850). For example, when the beam shaping device is an MLC, an optimized beamlet weight (and therefore a desired dose distribution) can be achieved by using different aperture shapes (also called segments) of the MLC to shape the delivered radiation. The weight of a beamlet is related to the dose rate. The dose rate refers to how much dose a linear accelerator or energy source can deliver per unit time. For a fixed dose rate, the beamlet weight is proportional to the amount of time the beamlet is active. For example, a beamlet can be operated by having an opening in the beam shaping device at a position corresponding to the beamlet so that radiation can pass through. For example, a higher weight means that the beamlet remains active for a longer time. Therefore, the weight of a beamlet is a function of the dose rate and / or the duration that the beamlet remains active.

[0105] The cost function 102 is a mathematical formula that relates the parameters 103 and the model 101. The cost function may be referred to as an objective function. The cost function 102 relates the dose distribution in the model 101 to a single value (the cost function value 109). For example, when the reference target is "the average dose to the bladder is less than 30 Gy", the cost function mathematically formulates and calculates the average dose to the bladder based on the parameters 103, and compares the achieved average dose to the reference 30 Gy. During optimization, the optimizer 107 looks for parameters that will minimize the difference between the achieved average dose and the reference average dose. The cost function value quantifies how close the dose in the model is to the expected value.

[0106] The cost function value 109 is the value of the cost function 102 when evaluated using the optimized parameter set. The cost function value 109 is calculated by the optimizer during optimization. The cost function value 109 can be called a penalty. Optionally, the cost function value 109 is output by the optimizer.

[0107] The cost function value 109 represents the penalty for violating the objective or constraint. The optimizer evaluates the penalty during optimization. Optionally, in constrained optimization, only the objective contributes to the cost function.

[0108] Constraints 105 include one or more conditions that must be satisfied by the optimization parameters 111. Constraints can be hard constraints (which set conditions that the parameters need to satisfy) or soft constraints (which have some variable values ​​that are penalized in the cost function when some conditions are not satisfied). Constraints limit the set of solutions that can be obtained. Constraints are used to define what is physically or clinically acceptable, rather than what is mathematically possible. For example, for IMRT, a constraint may be that the weights of beamlets must be non-negative (since negative beamlet weights are not possible). Note that constraints 105 are optional features.

[0109] The reference target 104 represents a target to be achieved. In one example, for IMRT, the reference target includes a dose-based target and / or a volume-based target. A dose target can be defined based on a dose value (in Gy). An example of a dose target can be stated as "the average dose to the OAR should be less than or equal to 30 Gy." A volume-based target can include a relative volume or an absolute volume. A relative volume represents a fraction of a volume. For example, a relative volume is a percentage. An absolute volume can be based on a physical size (e.g., in mm, cm, mm 3 、cm 3 The reference target 104 may be defined as a cost function 102 (e.g., in units of y Gy, etc.). An example of a volume-based target may be stated as "at least 90% of the volume of the PTV should meet a certain criterion". In another example, the reference target 104 may be stated as "at least X% of the first region receives at least Y Gy". The optimizer 107 may then determine optimization parameters 111 that result in an achieved target value 113 that is close to the reference target 104. The reference target may be referred to as a treatment planning target. Note that the reference target 104 is an optional feature. Additionally and optionally, the reference target 104 includes an indication of the cost function 102 to be used. Optionally, however, the reference target includes an indication of the anatomical structure to which the target to be achieved applies.

[0110] Reference targets are anatomically specific functions that establish dose and / or bioresponse targets. Constraints 105 are anatomically specific functions that must be satisfied. They may be referred to as hard constraints. When constraints are used with targets, the constraints are always satisfied, while the targets may not be satisfied (instead, they are goals that the optimizer attempts to achieve).

[0111] The cost function 102 together with the model 101, parameters 103, constraints 105 (optional) and reference target 104 (optional) define the problem to be solved.

[0112] The cost function 102, the constraint 105, and the reference target 104, alone or in any combination, may be referred to as a treatment planning goal. The treatment planning goal may be associated with an anatomical structure. In other words, the treatment planning goal may include any one of the cost function 102, the constraint 105, and the reference target 104. An example of a treatment planning goal may be stated as "97% of the PTV volume should receive a dose of at least 30 Gy using the "target penalty" cost function." Other examples of treatment planning goals are listed in rows m to x in the table.

[0113] The optimizer 107 aims to find an optimized set of parameters 111 for which the cost function 102 is minimized. The optimized parameters 111 are the output of the optimizer 107. In one example, when there is a reference target 104, the optimizer 107 minimizes the difference between the target value 113 (e.g., the output of the optimizer) and the reference target 104.

[0114] Optionally, the optimizer 107 outputs a cost function value 109. The cost function value 109 is the value of the cost function 102 when evaluated using the optimization parameters 111.

[0115] Optionally, the optimizer 107 outputs an achieved target value 113. The achieved target value 113 is comparable to the reference target. The achieved target value 113 represents a value having the same unit as a given reference target. The achieved value 113 may be different from the cost function value 109. Unlike the cost function value 109, which may be a number evaluated as a cost function, the achieved value 113 may have a physical meaning. In one example, when the reference target includes a dosimetry target in units of gray (Gy), the achieved target value also relates to the dose (e.g., it has the unit Gy and / or the same physical meaning as the reference target). In one example, when the reference target includes a reference volume and a dose value, the achieved target value also relates to the reference volume and the dose value (i.e., it has the same physical meaning as the reference target). As will be described below with respect to Table 1, the reference target may be based on DVH and may be a percentage of a volume for receiving a predetermined dose. The cost function value 109 may be a number corresponding to a cost function evaluated using an optimized parameter set. The achieved target value 113 will be the achieved percentage of a volume for receiving a predetermined dose. In other words, the achieved target value 113 is comparable to the reference target.

[0116] Figure 1B An example of a two-stage optimization process 150 for IMRT is shown. Although this example applies to IMRT, note that the optimization process 100 can be applied to other radiation therapy modalities. For example, the optimization process can also be applied to volumetric modulated radiation therapy (VMAT).

[0117] In IMRT, one or more radiation beams are directed to the tumor. The intensity of the individual beam profiles is non-uniform. The purpose of the optimization process 150 is to modify the intensity profile so that a sufficiently high dose is delivered to the tumor while reducing the dose delivered to healthy organs.

[0118] The optimization method of IMRT 150 includes two stages. The first stage 151 is the flux map optimization (FMO) and the second stage 153 is to determine the configuration of the radiation therapy system. In FMO (stage 151), the optimal flux map is determined. Then, the optimal flux map is used to determine the configuration of the radiation therapy system in stage 2. The FMO step 151 will be described next. Step 153 will be further described below.

[0119] For flux optimization, each beam is divided into a plurality of beamlets. Then, the contribution of each beamlet to the voxel at unit flux is calculated. Initially, the beamlets may be equally weighted and may contribute equally to the dose distribution. During optimization, the weights of each beamlet are adjusted so that the cost function is minimized. By multiplying the weight by the contribution of each beamlet at unit flux and then summing all beamlets, the full dose distribution may be obtained. The full dose distribution may be compared with any constraints and / or reference targets to determine whether the optimized solution is appropriate.

[0120] The optimization process of FMO can also be expressed as follows: The optimization process of FMO can be performed by the optimization process 100 described herein.

[0121] Optimization consists in minimizing a cost function f(x) by determining appropriate values ​​of the parameters x based on certain constraints g. For FMO, the parameters x correspond to the weights of the beamlets (x may also be referred to as decision variables, which are parameters that can be controlled). The output of FMO (stage 151) includes the parameters x.

[0122] The constraints g include limits. Examples of limits are a minimum dose at a voxel corresponding to a target, or a maximum dose at a voxel corresponding to an OAR, and so on.

[0123] In one example, the cost function f(x) is:

[0124] f(x)=T1+T2+...+T3

[0125] Among them, for example, T1 = ∑x n .d n , where x corresponds to the weight of the beamlet, d n It represents the dose delivered to a voxel by each beamlet at unit intensity. n is a non-optimizable parameter (e.g. it may depend on the machine configuration and / or the characteristics of the organization). ncan be obtained from the above model 101. For example, from the model 101, it is known whether the voxel n belongs to the target, OAR, etc. In one example, the dose d n It can be determined by a pencil beam algorithm, a convolution-based algorithm, and / or a Monte Carlo (MC)-based algorithm. Optionally, the dose calculation uses a pencil beam algorithm or a convolution-based algorithm (which is fast but has reduced accuracy). How the dose d can be determined n Additional details are in The training guide (Document ID: LTGMON0530 (Elekta AB)) is provided.

[0126] The output of Phase 1 may include dose distribution.

[0127] In this example, the cost function f(x) is the sum of the total doses (T1, T2 ... T3), where each of T1, T2 ... T3 represents the dose on a different structure. Note that alternative formulations of the problem to be solved may be used (e.g., by defining different cost functions or constraints).

[0128] In one example, a requirement for the dose at the target to be above a certain amount can be formulated as a constraint. Alternatively, such a requirement can be formulated as a reference target.

[0129] Step 151 provides an optimized set of parameters (e.g., beamlet weights x) that will provide an optimal intensity map (or flux map). In preparation for delivery by a radiotherapy system, a further step (step 153) is required to convert the individual optimized beamlet weights into a configuration of the machine that will deliver the optimal flux.

[0130] Next, the determination of the configuration (step 153) is described.

[0131] In step 153, the output from step 151 is converted into a configuration of a radiotherapy system. The configuration can be used by a radiotherapy device (examples of which are described herein) to deliver radiotherapy. For example, the configuration of the radiotherapy system includes a collection of aperture configurations (i.e., one or more aperture configurations). The shapes and weights of the aperture configurations are selected to meet the same goals as in the first stage. Here, the shape refers to the shape of the opening. The individual shapes can be referred to as segments. Here, the weights refer to the weights of the individual segments. The weights of the segments are related to the dose rate. For a fixed dose rate, the segment weight is proportional to the amount of time the beam is delivered through the segment. For example, a higher segment weight means a longer delivery time through the segment. Therefore, the weight of the segment is a function of the dose rate and / or the duration that the beam is delivered through the segment. The aperture configuration can be determined by a beam shaping device (e.g. Figure 8 When the beam shaping device is an MLC, the shape is defined by the leaf positions.

[0132] The aperture configuration may be referred to as control points or segments. The control points and / or segments include radiation information (eg, energy, dose) and geometric information (eg, gantry angle and leaf position).

[0133] The shape and weights of the apertures may be determined by applying algebraic and trigonometric considerations to the arrangement of the apertures in order to achieve the optimized beamlet weights of step 151 .

[0134] Alternatively, step 153 includes performing a second stage optimization process to determine an optimized aperture configuration that will achieve the optimized fluence pattern determined in step 151. The second stage optimization process may be referred to as aperture optimization or aperture refinement.

[0135] Aperture optimization can include the following:

[0136] - Receive a set of beamlet weights (eg, from step 151).

[0137] - Perform an optimization to determine the optimized aperture shape and optionally weights. The optimization can be performed using e.g. Figure 1A Other optimization procedures are also possible.

[0138] When the beam shaping device includes an MLC, aperture optimization may include:

[0139] - Receiving a set of beamlet weights from a FMO and / or a flux profile (eg from step 151 ).

[0140] - Convert the received profile into beamlet widths (openings between leaf pairs). This produces segments.

[0141] - Optimize the weights of the resulting segments.

[0142] - Optionally, optimizing the shapes of the generated segments (using a process known as segment shape optimization).

[0143] Note that the optimization step in step 153 may include calculation of a dose distribution. The dose distribution may be calculated using a pencil beam algorithm, a convolution-based algorithm, and / or a Monte Carlo (MC)-based algorithm. Optionally, the dose calculation in step 153 uses an MC-based algorithm (which is more accurate but computationally expensive).

[0144] Additional details on aperture optimization are given in The training guide (Document ID: LTGMON0530 (Elekta AB)) is provided.

[0145] As will be described in this article, Figure 2 and Figure 3In an embodiment, the step of determining the configuration of the radiotherapy system (step 153) is based at least on the set of optimization parameters and the relaxation target from stage one (step 151). In particular, when step 153 includes optimization, one or more relaxation targets may be used in the formulation of the optimization problem of step 153. By having one or more relaxation targets that are more appropriate, the optimization problem of step 153 may be improved (e.g., by having improved convergence or increasing the chance that the result of step 153 is appropriate).

[0146] Notice, Figure 1B The process involves a specific angle. In one approach, a previous step would be to determine the angle from which the radiation is delivered. Figure 1B The Beam Angle Optimization (BAO) process is performed before the process. Then, for each determined angle, Figure 1B process.

[0147] Although Figure 1B The example of relates to a two-stage optimization process for IMRT (FMO of step 151 and configuration determination of step 153), but note that alternative optimization methods such as direct machine parameter optimization (DMPO) may be used instead. In DMPO, the decision variables x correspond to parameters of the machine delivering radiation (e.g., MLC leaf positions). Alternatively again, the decision variables x may correspond to any one or more of the following: number of beams, beam angles, dose per beam, beamlet weights, segment or control point shapes, segment or control point weights, dose volume histogram information, dose excess values.

[0148] Returning to the cost function 102 in the optimization process 100, examples of cost functions include: target EUD, target penalty, secondary overdose, secondary underdose, continuous, parallel, maximum dose, overdose DVH, underdose DVH. The cost function is briefly defined below. Each cost function provides a different calculation method.

[0149] When the cost function includes any of target penalty, parallelism, overdose DVH, and underdose DVH, the reference target is a dose value and a relative volume component (eg, percentage) or an absolute volume (eg, in cc).

[0150] When the cost function includes any of target EUD, secondary overdose, continuous, maximum dose, or conformality, the reference target is the dose value.

[0151] Cost functions such as sequential, parallel, quadratic overdose, overdose DVH or maximum dose are intended to limit the dose at the anatomical structure. For example, for these cost functions, the penalty increases when the achieved dose exceeds the reference dose. The higher the achieved dose is above the reference dose, the more likely the penalty will increase.

[0152] Cost functions such as secondary underdose or underdose DVH aim to increase the dose at the anatomical structure. Cost functions such as target EUD and target penalty aim to increase the dose at the structure. For example, these cost functions are used for the target or PTV. For these cost functions, the penalty increases when the achieved dose is below the reference dose. The lower the achieved dose is than the reference dose, the more likely the penalty will increase.

[0153] Some of the above cost functions also take a unitless number as input. The unitless number (k) is the power law exponent.

[0154] The target EUD cost function defines the structure as the target volume and expresses the probability of target cells surviving at a given dose. The cost function requires a specified dose as input (i.e., the reference target of the cost function is the dose value). The specified dose in Gy is the equivalent uniform dose (EUD). EUD is a uniform dose that, if delivered at the anatomical structure, has the same clinical effect as a non-uniform dose distribution.

[0155] The target penalty cost function takes as input a prescribed dose and a minimum volume (i.e., the reference targets of the cost function are dose and relative volume). The target penalty is a quadratic penalty that starts with a threshold dose. It produces a steeper dose gradient after the target threshold is met. The target penalty is used to define the requirement that at least some portion of the total anatomical volume should receive at least the target dose.

[0156] The quadratic dose overdose (QO) cost function is a cost function used to limit the dose in the structure to which the dose is applied. QO can be applied to the target or OAR. The QO cost function can be used to limit hot spots in the target. The QO cost function takes as input the maximum dose and the root mean square (RMS) dose overdose (i.e., the reference target includes two dose values). The maximum dose defines the dose above which a penalty occurs. The RMS dose overdose defines the acceptable amount of violation.

[0157] The quadratic underdose cost function is a cost function applied to the target volume. The quadratic underdose function implements a quadratic penalty. The cost function takes as input the minimum dose in Gy and the dose deficit in Gy (i.e., the reference target includes two dose values). The minimum dose is the minimum dose allowable in the target and represents the dose below which the penalty occurs. The dose deficit is similar to the RMS dose overdose in that it defines the amount of acceptable prescription violation.

[0158] The continuous cost function is often used with continuous OARs. Continuous anatomical structures are structures where high doses are harmful even if they are confined to a small volume. Examples include the spinal cord and intestine. This cost function imposes a large penalty on hot spots even if they are small in volume. The cost function takes as input the EUD in Gy and a power law exponent k (i.e., the reference target includes both the dose value and the unitless number).

[0159] Parallel cost functions are often used for parallel OARs. Parallel structures are structures that tolerate very high doses in a small volume while the rest of the organ is protected. Examples are lung, parotid, kidney, liver. The cost function takes as input a reference dose in Gy, an average organ damage (which is the fraction of the volume of the structure that can be sacrificed), and a power law exponent k (i.e., a reference target includes a dose value, a relative volume, and a unitless number).

[0160] The maximum dose cost function is effectively a hard barrier that can be applied to target structures or OARs. The maximum dose cost function has a penalty that takes effect whenever a voxel crosses a maximum dose threshold. The cost function takes as input the maximum dose in Gy (ie, the reference target includes the dose value).

[0161] The overdose DVH cost function takes as input a target dose in Gy and a maximum volume (i.e., a reference target includes a dose value and a relative volume). This cost function is applied to OARs. The goal is to keep the volume that receives more than the target dose below the relative volume.

[0162] The underdose DVH cost function takes as input a target dose in Gy and a minimum volume (i.e., a reference target includes a dose value and a relative volume). The cost function is applied to the target. The goal is to keep the target volume that receives less than the target dose above the minimum volume.

[0163] Additional details of the cost function are given in The training guide (Document ID: LTGMON0530 (Elekta AB)) is provided.

[0164] Figure 2 A flow chart of a method for radiotherapy planning according to an embodiment is shown. The method is used to plan a radiotherapy treatment plan by a radiotherapy system (e.g. Figure 7 Radiation therapy system 600) is used to implement radiation therapy. Figure 2 The method can be obtained by Figure 7 The treatment planning system 610 is described as performing.

[0165] In step 201, a reference target is received. The reference target represents a target to be achieved when delivering radiation through a radiation system. Optionally, the target is a clinical target specified by a user (e.g., a physician). For example, the reference target includes a reference dose and / or a reference volume. The reference target corresponds to the reference target 104 described herein.

[0166] In step 203, an optimization process is performed to optimize a set of parameters (i.e., one or more parameters). Step 203 may also be referred to as a first pass optimization. The optimization is performed according to the received reference target. The purpose of the first pass optimization is to determine the parameter values ​​that will achieve the reference target. Step 203 includes steps 2031 and 2033. Optionally, in step 203, a cost function to be used during optimization is received. The cost function may be provided by a user.

[0167] In step 2031, one or more parameters are optimized and an implementation value (e.g., a first-pass implementation value) is obtained. For example, the optimization of step 2031 can be performed by Figure 1A The first pass achieves the value corresponding to the value obtained by Figure 1A The first pass achieves the target value of the optimization process. Figure 1A The described achievement target value is 113.

[0168] In step 2033, a relaxation target is obtained using a relaxation value (e.g., a first-pass relaxation value). The relaxation target is obtained by modifying the realization value using the first-pass relaxation value. The relaxation target may be referred to as a first-pass relaxation target. Optionally, in response to the first-pass realization value not satisfying the reference target 201, step 2033 is performed. Not satisfying the reference target by the first-pass realization value means that the first-pass realization value deviates from the reference target by at least a predetermined amount. The first-pass realization value after step 2031 may be different for a variety of reasons. For example, the received reference target may have been too strict, and the parameter set that will achieve the reference target may not be available, so that the first-pass value in step 2031 does not reach the reference target. In this case, the first-pass realization value corresponds to a solution that can be obtained when trying to achieve the treatment plan goal. Note that, conversely, satisfying the reference target by the first-pass realization value means that the first-pass realization value deviates from the reference target by less than a predetermined amount.

[0169] A relaxation target (e.g., a first-pass relaxation target) is obtained using the first-pass relaxation values ​​(step 2033). The first-pass relaxation target may not be as strict as the achieved value. For example, the first-pass relaxation target may be farther from the reference target than the first-pass achieved value. For example, the difference between the first-pass relaxation target and the reference target may be greater than the difference between the first-pass achieved value and the reference target. For example, when the reference target involves a dose value and an anatomical structure (e.g., a PTV or a target) to which a sufficiently high dose is desired to be delivered, the relaxation target may include a dose value that is lower than the achieved value. Conversely, when the reference target involves a dose value and an anatomical structure (e.g., an OAR) to which a reduced dose is desired to be delivered, the relaxation target may include a dose value that is larger than the achieved value.

[0170] For example, a reference target may be "the average dose to the rectum should be ≤30Gy", but, after a first pass of optimization, a minimum average dose of 32Gy to the rectum was achieved (achieved value = 32Gy). The relaxation target may then become "the average dose to the rectum should be ≤33Gy". Here, a relaxation value of 1Gy is added to the achieved value of 32Gy to obtain a relaxation target "the average dose to the rectum should be ≤33Gy". The relaxation target is less strict than the achieved value. The relaxation target is further from the reference target (33Gy vs. 30Gy) than the achieved value is from the reference target (32Gy vs. 30Gy). Although in this example, the reference target and the relaxation target are defined based on dose, note that the reference target and the relaxation target may be defined based on volume or based on dose and volume.

[0171] The first pass relaxation target can be considered as the output of the first pass optimization 203. The first pass relaxation target is then used in subsequent steps. For example, the first pass relaxation target is used as a constraint for subsequent optimization steps. Obtaining the first pass relaxation target value by using the relaxation value means modifying the first pass realization value to be used as the first pass relaxation target. Modifying the realization value may include multiplying, dividing, adding or subtracting the first relaxation value and the first realization value to obtain one or more of the relaxation targets. The first relaxation value represents the deviation between the first pass relaxation target and the first pass realization value.

[0172] In addition and optionally, the first relaxation value is defined as a ratio or percentage (%). When the first relaxation value is defined as a ratio or percentage (%), applying the first relaxation value to the first target value means increasing or decreasing the relaxation value of the first target value. An example of the first relaxation value is 3%. Other examples of the first relaxation value include 2%, 5% or 10%.

[0173] In step 204, the configuration of the radiotherapy system is determined based on the set optimization parameters and the first pass relaxation target from step 203. Step 204 corresponds to Figure 1B Step 153.

[0174] Additionally and optionally, in response to the first pass realization value from step 2031 satisfying the reference target, step 2033 is skipped. Then, reference target 201 can be used for subsequent steps. Reference target 201 is used instead of realization value.

[0175] In the first pass, the optimizer may find a solution that is a certain distance from the reference. Defining constraints based on the achieved solution and the slack values ​​and allowing the optimization process to proceed to subsequent steps may produce a more accurate solution. This reduces the chances of stopping the optimization process after the first pass to obtain input from the user (e.g., modify the reference), while also appropriately constraining the optimization of subsequent steps.

[0176] In step 205, the configuration obtained in step 204 is output for use by the radiation therapy system. Step 205 is optional.

[0177] Next, we describe Figure 2 An example of a method. In one example, the reference target is to obtain a dose less than or equal to 30 Gy. A first pass optimization is performed (step 203). In step 2031, the parameters are optimized, and the achieved value (first pass achieved value) can be, for example, 35 Gy. Therefore, the first pass achieved value does not meet the reference target. In step 2033, the relaxation value is applied to the first pass achieved value to obtain a first pass relaxation target. The first pass relaxation target is then 35 Gy + 1 Gy = 36 Gy. Here, the relaxation value of 1 Gy is added to the first pass achieved value of 35 Gy. The first pass relaxation target is used in subsequent steps 204 and 205.

[0178] The purpose of modifying the first pass realization value using the relaxation value to obtain the first pass relaxation target is to "give room" to the subsequent steps that use the first pass relaxation target. In particular, when the first pass relaxation target is used as a constraint, a wider solution space can be accessed (compared to the case where no relaxation is applied). This can improve the performance of the method.

[0179] Figure 3 A flow chart of a method for implementing a radiation therapy plan for radiation therapy by a radiation therapy system according to an embodiment is shown. The method is used to implement a radiation therapy plan by a radiation therapy system (e.g. Figure 7 Radiation therapy system 600) is used to implement radiation therapy. Figure 3 The method can be obtained by Figure 7 The treatment planning system 610 is described as performing.

[0180] The method includes steps 301, 303A, 303B, 304 and 305. Steps 301, 304 and 305 correspond to Figure 2 Step 303A may be referred to as a first pass optimization, and step 303B may be referred to as a second pass optimization. The second pass optimization (step 303B) is performed after the first pass optimization (step 303A). Step 303B uses the optimization parameters of step 303A as a starting point. Step 303A and step 303B may be collectively referred to as an optimization process.

[0181] In step 303A, one or more parameters are optimized. The purpose of the optimization is to determine parameters that will achieve the reference target received in step 301. Step 303A corresponds to step 203. The output of step 303A includes a set of optimized parameters and one or more of a first pass achieved value and a first pass relaxed target.

[0182] In step 303B, the parameters are further optimized. By further optimizing, it is meant that the optimized parameter set from the previous step is used as a starting point for the optimization process. Additionally and optionally, step 303B is performed in response to the first pass achieved values ​​(from step 303A) satisfying the reference target 301. Alternatively and optionally, the first pass optimization step 303A corresponds to Figure 2 203, and when the first-pass achieved value does not satisfy the reference target, step 303B is skipped, and the first-pass relaxed target from the first pass is used in a subsequent step (step 303A).

[0183] Returning to step 303B, step 303B includes steps 3035 and 3037. In step 3035, the parameters from step 303A are further optimized to obtain a second pass realization value. Optionally, the optimization can be based on the reference target 301. The second pass realization value corresponds to the value of Figure 1A The second pass realization value from step 3035 is modified using the second pass relaxation value to obtain the second pass relaxation target. The output of step 3035 is the second pass realization value. The second pass realization value is similar to Figure 2 The first pass realization value obtained in step 2031 of , except that it is obtained from the subsequent optimization step 3035. The second pass realization value is modified using the second pass relaxation value to obtain the second pass relaxation value (step 3037) similar to Figure 2 Step 2033.

[0184] In step 304, the configuration of the radiation therapy system is determined based on the set optimization parameters and the second pass relaxation target from step 303B. Step 304 corresponds to Figure 1B In step 305, the configuration obtained in step 304 is output for use by the radiation therapy system. Step 305 is optional.

[0185] In About Figure 2 and Figure 3 In the described method, additionally and optionally, the second pass relaxation value is less than the first pass relaxation value. This can further improve the optimization process. In step 303A, the optimizer has covered a wide solution space. In the second optimization step 303B, the smaller relaxation parameter narrows the solution space and leads to improved optimization.

[0186] Additionally and optionally, the second relaxation value is between 25% and 75% of the first relaxation value. Further optionally, the second relaxation value is 50% of the first relaxation value.

[0187] In About Figure 2 and Figure 3In the described method, additionally and optionally, the first pass and / or second pass relaxation values ​​are defined relative to a reference target (which may include a dose value) or relative to an achieved value (e.g., as a ratio or percentage (%) of the reference target). An example of a relaxation value is 3%. Other examples of relaxation values ​​include 2%, 5%, or 10%. When the relaxation value is a ratio or percentage, the relaxation can be bounded by a lower limit value and an upper limit value. The upper limit value may be different from the lower limit value. For example, the relaxation value is 3% (of the achieved value), the lower limit is 0.6 Gy, and the upper limit is 1.2 Gy. If the achieved value is 50 Gy, then in the case of 3% relaxation, the achieved value should be relaxed 50*0.03=1.5 Gy. Since the value of 1.5 Gy exceeds the upper limit value of 1.2 Gy, the relaxation value is limited to an amount of 1.2 Gy. Therefore, the relaxation target can be obtained from the realized value (50Gy) and the bounded relaxation value of 1.2Gy (1.5Gy is limited to the upper limit of 1.2Gy), and the relaxation target may include a dose value of 50+1.2=51.2Gy. In another example, when the realized value is 30Gy, then with 3% relaxation, the realized value we should relax 30*0.03=0.9Gy. Since 0.9Gy is within the limit (0.6-1.2Gy), the relaxation target may include a dose value of 30+0.9=30.9Gy. The lower limit value and the upper limit value of the second optimization (step 303B) may be different from the lower limit value and the upper limit value of the first optimization (step 303A). The purpose of the lower limit and the upper limit is to enable the relaxation target to be within a more appropriate range.

[0188] In About Figure 2 and Figure 3 In the described method, an additional and optional step is to set the first and / or second relaxation value according to the cost function. The purpose is to use a relaxation value that is more suitable for the cost function used (rather than using the same relaxation value for any cost function). This can improve the optimization process. Note that, optionally, the cost function is received before the optimization step 203 or 303A. For example, in step 201 or 301, a cost function and a reference target are received.

[0189] Additionally and optionally, the relaxation values ​​for each cost function may be predetermined. Relaxation values ​​and their corresponding cost functions may be stored in a memory and may be retrieved for use during optimization. Alternatively, relaxation values ​​are received before optimization step 203 or 303A. Relaxation values ​​may be obtained together with the cost function. For example, relaxation values ​​may be user defined.

[0190] Return to Figure 2 and Figure 3 In the illustrated method, it is noted that one reference target is received (step 201 or step 301). However, additionally and optionally, multiple reference targets are received. Each reference target is processed in turn.

[0191] Figure 4 A flow chart of a method for radiotherapy planning according to an embodiment is shown. The method is used to plan a radiotherapy treatment plan by a radiotherapy system (e.g. Figure 7 Radiation therapy system 600) is used to implement radiation therapy. Figure 4 The method can be obtained by Figure 7 The treatment planning system 610 is described as performing.

[0192] The method includes steps 901, 903, 905, 907, and 909. Steps 907 and 909 correspond to steps 204 and 205, respectively. Step 901 is similar to step 201 or 301, except that first and second reference targets are received. The first reference target may be referred to as a reference target, and the second reference target may be referred to as an additional reference target. Step 903 may be referred to as a first pass optimization, and step 905 may be referred to as a second pass optimization.

[0193] In step 903, each received target is acquired in sequence, and a first pass optimization (pass 1 optimization) is performed on each received target. Step 903 includes step 903A in which a first pass optimization based on a first reference target is performed and step 903B in which a first pass optimization based on a second reference target is performed.

[0194] The purpose of step 903A is to determine parameters that will achieve the first reference target received in step 901. Step 903A corresponds to step 203 or 303A.

[0195] In more detail, step 903A includes the following steps.

[0196] - Optimizing a parameter set based on a first reference objective and obtaining a first pass achieved value.

[0197] In response to the first-pass achieved value not satisfying the first reference target, obtaining a first-pass relaxed target using the first-pass relaxed value.

[0198] - The first pass relaxed target can be considered as the output of the first pass optimization 903A. The first pass relaxed target can be used in subsequent steps.

[0199] After performing the first optimization pass based on the first target (step 903A), another first optimization pass based on the second reference target is performed (step 903B). The purpose of step 903B is to determine the parameters that will achieve the second reference target received in step 901. Step 903B corresponds to step 203 or 303A.

[0200] In more detail, step 903B includes the following steps.

[0201] - Further optimize the parameter set from step 903A based on the second reference target and using the first pass relaxed target obtained from step 903A as a constraint. Obtain additional first pass realized values. This step is performed when the first pass realized values ​​from step 903A do not meet the first reference target.

[0202] In response to the first pass realization value from step 903A satisfying the first reference objective, further optimizing the parameter set from step 903A based on the second reference objective and using the first reference objective from step 901 as a constraint to obtain an additional first pass realization value. In other words, in step 903B, no relaxation is applied and the first reference objective is used as a constraint. An additional first pass realization value is obtained. The additional first pass realization value can be considered as an output of step 903B.

[0203] In response to the additional first-pass realization value in step 903B not satisfying the second reference target, obtaining an additional first-pass relaxation target using the first-pass relaxation value. Alternatively, in response to the additional first-pass realization value in step 903B satisfying the second reference target, no relaxation is applied, and the second reference target can be used as a constraint in subsequent steps.

[0204] Returning to step 903, the output of step 903 may be considered to be the set of optimized parameters obtained in step 903B. The output may also include any one or more of the first-pass relaxed targets from step 903A and the additional first-pass relaxed targets of step 903B.

[0205] After the first optimization pass (step 903 ), a second optimization pass is performed at step 905 .

[0206] In step 905, each received target from step 901 is obtained in sequence, and a second pass optimization (pass 2 optimization) is performed on each received target. Step 905 includes step 905A in which a second pass optimization based on a first reference target is performed and step 905B in which a second pass optimization based on a second reference target is performed. Note that, as described herein, in some cases (by Figure 4 ), steps 905A and 905B may be skipped.

[0207] The purpose of step 905A is to determine, starting from the set of optimized parameters obtained in step 903, the parameters that will achieve the first reference target received in step 901. Step 905A corresponds to step 303B.

[0208] In more detail, step 905A includes the following steps.

[0209] - In response to the first pass realization value from step 903A satisfying the first reference target, further optimizing the parameter set from step 903 based on the first reference target and obtaining a second pass realization value. This step corresponds to step 303B.

[0210] - The second pass relaxation value is used to modify the second pass realization value to obtain the second pass relaxation target. The output of step 905A includes the second pass realization value and the second pass relaxation target.

[0211] - In response to the first pass realized values ​​from step 903A not satisfying the first reference target, no further optimization is performed (ie, step 905A is skipped). Instead, the first pass relaxed targets from step 903 are used in subsequent steps.

[0212] After performing the second optimization pass based on the first objective (step 905A), another second optimization pass based on the second reference objective is performed (step 905B). The purpose of step 905B is to determine the parameters that will achieve the second reference objective received in step 901. Step 905B corresponds to step 303B.

[0213] In more detail, step 905B includes the following steps.

[0214] - In response to the additional first pass realization value from step 903B satisfying the second reference target, further optimizing the parameter set from step 903B based on the second reference target. Obtain additional second pass realization value. This step corresponds to step 303B.

[0215] - The second-pass relaxation value is used to modify the further second-pass realization value to obtain the further second-pass relaxation target. The output of step 905B includes the further second-pass realization value and the further second-pass relaxation target.

[0216] - In response to the additional first-pass realized values ​​from step 903B not satisfying the first reference target, no further optimization is performed (ie, step 905B is skipped). Instead, the additional first-pass relaxed targets from step 903 are used in subsequent steps.

[0217] Returning to step 905, the output of step 905 can be considered as the optimized parameter set obtained in step 905A or 905B (if step 905B has been performed). The output can also include any one or more of the second pass relaxation target from step 905A and the additional second pass relaxation target of step 905B.

[0218] Steps 903 and 905 together correspond to the integral flux map optimization step 902. Step 902 corresponds to Figure 1BStep 151. From step 902, the following are obtained: the optimization parameter set from the second optimization pass (step 905) and any one of the following:

[0219] - the first pass relaxation target from step 903A and the additional first pass relaxation target from step 903B;

[0220] - the first pass relaxation target from step 903A and the additional second pass relaxation target from step 905B;

[0221] - Another first pass relaxation target of step 903B, the second pass relaxation target from step 905A; or

[0222] - The second pass relaxation target from step 905A and the additional second pass relaxation target from step 905B.

[0223] In step 907, a configuration of the radiation therapy system is determined based on the optimized parameter set and the relaxation target from step 902. Step 907 corresponds to Figure 1B In step 909, the configuration obtained in step 907 is output for use by the radiation therapy system. Step 909 is optional.

[0224] about Figure 4 , note about Figure 2 or Figure 3 Any additional and optional features described are also applicable.

[0225] More about Figure 4 When the first and / or second relaxation values ​​are based on a cost function, note that the first-pass relaxation value used in step 903A may be different from the first-pass relaxation value used in step 903B. Similarly, the second-pass relaxation value used in step 905A may be different from the second-pass relaxation value used in step 905B.

[0226] although Figure 4 Includes the first and second goals, but Figure 4 The method is applicable to three or more reference targets.

[0227] Next, an example with multiple targets is described. When there are multiple targets, the priorities of the targets can be distinguished, and each target can be acquired in sequence based on its priority.

[0228] In a simplified example, for the case of prostate cancer, three objectives with different priorities can be defined. There may be some hard constraints to ensure that the tumor receives an adequate dose.

[0229] The goals can be:

[0230] - Priority 1: The mean dose to the rectum should be less than or equal to 30 Gy.

[0231] - Priority 2: The mean dose to the bladder should be less than or equal to 35 Gy.

[0232] - Priority 3: Maximum dose to the rectum should be less than or equal to 50 Gy.

[0233] Use something like Figure 4 In the embodiment of the present invention, in pass 1, the optimizer tries to satisfy each goal one by one based on the priority (the optimizer will first try the goal with priority 1, then try priority 2, 3...), and in pass 2, the optimizer only visits the goals satisfied in pass 1 and tries to optimize further.

[0234] In more detail, in pass 1 ( Figure 4 In step 903):

[0235] 1) The optimizer attempts to reduce the average dose to the rectum (step 903A). After the optimization process is completed, the minimum average dose to the rectum obtained from the optimizer is 32 Gy. Then the target cannot be achieved (reference target: average dose of 30 Gy). Therefore, the target is modified using the first-pass relaxation value (e.g., first-pass relaxation value = 1 Gy) to obtain a first-pass relaxation target of 33 Gy (achievement value 32 Gy + relaxation value 1 Gy). Then, a relaxation target with an average dose to the rectum less than or equal to 33 Gy (32 and 1 Gy relaxation) can be used in subsequent steps.

[0236] 2) The optimizer attempts to reduce the average dose to the bladder (step 903B), which uses the average dose to the rectum ≤ 33 Gy as a constraint (the first pass relaxed target from the priority 1 optimization is used as the constraint for step 903B). After the optimization process is completed, the average dose to the bladder obtained from the optimizer is 26 Gy (the other first pass achieved value = 26 Gy). Therefore, the target is achieved (reference target: average dose of 35 Gy). Therefore, this reference target (average dose to the bladder is less than or equal to 35 Gy) is used in subsequent steps.

[0237] 3) The optimizer attempts to reduce the maximum dose to the rectum (step 903B), using the average dose to the rectum ≤ 33 Gy (the first pass relaxed target from the priority 1 optimization) and the average dose to the bladder ≤ 35 Gy as constraints (the reference target of the priority 2 optimization). After the optimization process is completed, the maximum dose to the rectum obtained from the optimizer is 45 Gy (the other first pass achieved value = 45 Gy). Therefore, the target (reference target: maximum dose of 50 Gy) is achieved. Therefore, this reference target (maximum dose to the bladder less than or equal to 50 Gy) is used in subsequent steps.

[0238] In the 2nd ( Figure 4 In step 905):

[0239] 1) Priority 1 is skipped because the goal was not achieved in pass 1 (so the optimizer will not do anything more for this priority). Instead, the first pass relaxed goal (average dose to the rectum less than or equal to 33 Gy) is used in subsequent steps.

[0240] 2) The optimizer attempts to reduce the average dose to the bladder (step 905B), which uses the average dose to the rectum ≤ 33 Gy and the average dose to the bladder ≤ 35 Gy as constraints. After the optimization process is completed, the average dose to the bladder obtained from the optimizer is 28 Gy (second pass achieved value = 28 Gy). Therefore, the second pass achieved value meets the reference target (30 Gy). The second pass relaxation value (e.g., 0.5 Gy) is used to modify the achieved value to obtain the second pass relaxed target: the average dose to the bladder ≤ 28.5 Gy (= 28 + 0.5 Gy). The relaxed target of the average dose to the bladder ≤ 28.5 Gy is used in subsequent steps.

[0241] 3) The optimizer attempts to reduce the maximum dose to the rectum, using the average dose to the rectum ≤ 33 Gy and the average dose to the bladder ≤ 28.5 Gy (relaxed targets from the second pass optimization at priority 2) as constraints. After the optimization process is completed, the maximum dose to the rectum obtained from the optimizer is 47 Gy (additional second pass achieved value = 47 Gy). Therefore, the reference target is met. The second relaxed value (e.g., 0.5 Gy) is used to modify the achieved value to obtain a second pass relaxed target of ≤ 47.5 Gy (= 47 + 0.5 Gy) for the maximum dose to the rectum. The relaxed target of ≤ 47.5 Gy for the maximum dose to the rectum is used in subsequent steps.

[0242] The following goals are obtained from the two passes (step 902):

[0243] 1) The average dose to the rectum should be less than or equal to 33 Gy.

[0244] 2) The average dose to the bladder should be less than or equal to 28.5 Gy.

[0245] 3) The maximum dose to the rectum should be less than or equal to 47.5 Gy.

[0246] refer to Figure 4 The method uses these targets in steps 907 and 909.

[0247] Next, an example of a wish list will be described with reference to Table 1. The wish list represents a clinical prescription. The clinical prescription can be defined by a user and defines what is expected to be achieved. The wish list includes one or more goals. Here, the goal corresponds to the reference goal 104, 201 or 301 described herein. Alternatively (not shown in Table 1), the goal can be formulated as a constraint instead. The constraint refers to the constraint 105 described herein.

[0248] An example of a portion of a wish list for radiation therapy for prostate cancer is described below.

[0249] Table 1: Example of a wish list

[0250]

[0251]

[0252] The expectation list shown in Table 1 includes the following.

[0253] The wish list includes "clinical" constraints (rows a to f). Violation of these constraints means plan rejection. The wish list also includes "planning" constraints (rows g to l). The purpose of "planning" constraints is to achieve dose conformality and control potential hot spots.

[0254] Clinical constraints and planning constraints are predefined constraints. For example, Figure 4 Step 407 may refer to checking whether such clinical constraints are met. The purpose of the constraints in rows a to l is to limit the dose at the corresponding structure.

[0255] In Table 1, the structure name represents the anatomical structure. The structure is obtained by a process called segmentation, in which contours are drawn on slices of MRI images or CT images to identify different structures. The contours can be generated manually (e.g., by a physician, dosimetrist, or health worker) or automatically using atlas-based automatic segmentation software.

[0256] The wish list also includes prioritized targets (rows m to x). The prioritized targets each correspond to a reference target as described herein. Prioritized targets include targets related to dose coverage and conformality of the target (which are the 1st priority targets in rows m to q) and targets related to dose protection of OARs (rows r to y). Prioritized targets can be user defined priorities.

[0257] In Table 1, "Cost Function (Parameter Values)" relates to the type of cost function to be used. For some cost functions, additional parameters are provided. "Target" refers to the dose or volume to be achieved by the treatment planning system.

[0258] For example, in row m, the reference target is 97% of the urethral PRV (a) to achieve a dose of 33.2 Gy. The cost function associated with the reference target is the "target penalty".

[0259] For each structure, one or more cost functions and associated objectives are defined, each achieving a different purpose. For example, at rows r to t, for the "rectum" structure, different cost functions and objectives are applied.

[0260] In Table 1, the priority refers to the relative priority of the referenced objectives. In Table 1, the objectives related to dose coverage and conformality of the target (which are the 1st priority objectives in rows m to q) are optimized first, and then the objectives related to dose protection of OARs (rows r to y) are optimized, in the order of their priorities.

[0261] In Table 1, the hierarchical order refers to the volume of overlapping structures. When structures include overlapping voxels, the structure with the higher hierarchical order "owns" the voxel.

[0262] Further examples of wish lists are provided in Naccarato, S., Rigo, M., Pellegrini, R., Voet, P., Akhiat, H., Gurrera, D., De Simone, A., Sicignano, G., Mazzola, R., Figlia, V. and Ricchetti, F., 2022. Automated planning for prostate stereotactic body radiation therapy on the 1.5T MR-Linac. Advances in radiation oncology, 7(3), p.100865.

[0263] Figure 5 A flow chart of an optimization process for a radiation therapy plan according to an embodiment is shown. The method is used to perform a radiation therapy system (e.g. Figure 7 Radiation therapy system 600) is used to implement radiation therapy. Figure 5 The method can be obtained by Figure 7 The treatment planning system 610 is described as performing.

[0264] In step 401, optimization begins.

[0265] In step 403, the contribution of each beamlet to the voxel at unit flux is calculated.

[0266] In step 404, a first optimization pass (pass 1 optimization) is performed. In order to perform the optimization, one or more objectives may be obtained. The objectives are prioritized and each objective is considered in turn based on its priority. As described herein, an objective represents a clinical objective to be achieved. An objective may be referred to as a treatment plan objective. Step 404 includes steps 405, 407, 409, 411, 413, 415, 417, 419, and 421.

[0267] At step 405, an optimization is performed for a first objective of the one or more objectives. The optimization is performed taking into account predefined constraints. The optimization step 405 may correspond to the optimization block 100 described herein. The output of the optimization step 405 is a parameter set and an achieved value.

[0268] In step 407, it is checked whether the output of the optimization in step 405 satisfies the constraints. If the constraints are not satisfied, then in step 409, the process is stopped. The problem is considered infeasible and the user is required to modify the wish list. If the constraints can be satisfied, the method proceeds to step 411.

[0269] In step 411, it is checked whether the first priority target meets its clinical target. In other words, it is checked whether the achieved value after the optimization in step 407 meets the first priority target (reference target).

[0270] When the goal is met (or better than) at step 413, the constraint is set to the goal value (i.e., the reference goal). The constraint is intended to be used in subsequent steps. For example, the subsequent steps include a first pass optimization of another goal, a second pass optimization of the same prioritized goal, or a step after the optimization process. The second pass is described below with respect to Figure 6 The purpose of step 413 is to leave space in the solution space for subsequent optimization.

[0271] When the objective is not met, at step 415, the constraint is instead set to a relaxed value. The relaxed value is obtained by applying the relaxed value to the achieved value obtained after the optimization at step 405. The relaxed value is intended to be used in subsequent steps (e.g., a first pass optimization of another objective, a second pass optimization of the same objective (see below for details). Figure 5 description), or a step after the optimization process). The relaxed value is the first pass relaxation target.

[0272] At step 417, the next target is considered.

[0273] In step 419, steps 405 to 417 are repeated for all targets. Thus, for each target, a first pass of optimization (steps 405 to 417) is performed and an achieved value is obtained. For each target, a constraint is obtained. If the achieved value satisfies the reference target (step 413), the constraint is set to the target (reference target), or if the target cannot be met (step 415), the constraint is set to a relaxed value. For targets that achieve better results than the target value (reference target), the cost function is revisited in a second pass of optimization.

[0274] At step 421, the first pass of optimization is completed and the process moves to Figure 6 Describes the second pass optimization.

[0275] Figure 6 A flow chart of an optimization process for radiation therapy planning according to an embodiment is shown. Figure 6 The method shown follows Figure 5 The steps performed in the method. Figure 6 The second optimization pass is described in the flowchart of FIG. Figure 7 Radiation therapy system 600) is used to implement radiation therapy. Figure 6 The method can be obtained by Figure 7 The treatment planning system 610 is described as performing.

[0276] In step 501, the second optimization pass begins. The second optimization pass is to have Figure 5 The second optimization pass uses the parameters obtained after the first optimization pass described in Figure 5 The constraints determined in step 413 or 415 in the first pass.

[0277] In step 502, each target is considered in turn. Step 502 includes steps 503 to 521.

[0278] In step 503, check whether the first priority goal meets the achievement goal from the first pass. In other words, check whether the first priority goal meets the achievement goal from the first pass. Figure 5 The achieved value obtained after the optimization of step 405 satisfies the first priority target (reference target). When the first priority target does not meet the achieved target from the first pass, no further optimization is performed on that priority target. At step 505, the constraint is maintained at its current value. This constraint is used in subsequent steps. Then, the process moves to the next target at step 521.

[0279] At step 503 , when the first priority goal meets the achievement goal from the first pass, the method proceeds to step 507 .

[0280] In step 507, it is checked whether there are sufficient values. The sufficient values ​​are a predetermined condition. If there are sufficient values, the method proceeds to step 509, if not, proceeds to step 517.

[0281] A sufficient value is a value that is considered good enough from a clinical point of view. For example, it is desirable to protect the parotid gland by reducing the average dose to the parotid gland. The probability of complications at the 10 Gy level is very low. This means that attempting to reduce the dose to the parotid gland from 10 Gy to 5 Gy may come at the cost of planning complexity (and lead to potential problems with plan QA) and may lead to increased treatment delivery time without any clinical benefit to the patient. By having a sufficient value of 10 Gy, the optimizer is stopped from pushing further down (i.e., the optimizer is prevented from making calculations once a good enough achievement of the target is obtained).

[0282] At step 509, further optimization is performed until the first priority target (ie, the optimized achieved value) meets or exceeds the sufficient value. For example, the first priority target is pushed as low as possible (ie, optimization is performed), but stops at the sufficient value.

[0283] In step 511, it is checked whether a sufficient value has been reached. If so, in step 513, the sufficient value is used as a constraint (rather than a target). This constraint is used in subsequent steps.

[0284] If the sufficient value is not reached, then in step 515, the constraint is set to the realized value relaxed by the second relaxation value. In other words, the second relaxation value is applied to the realized value to obtain a second relaxation target, and the second relaxation target is used as a constraint in subsequent steps. Then, the method proceeds to step 521.

[0285] The purpose of steps 503, 507, 509, 511, 513 and 515 is to revisit the achieved target value from the first pass of optimization (the achieved target value has satisfied the reference target from the first pass) so that the achieved target value reaches a sufficient value or its lowest possible value (i.e., to make the achieved target value more suitable for the relaxation value to be applied to obtain a more suitable second relaxation target value).

[0286] Returning to step 507, when there are not enough values, the method proceeds to step 517. In step 517, further optimization is performed so that the first priority target is optimized (i.e., the achieved value obtained after optimization is pushed as low as possible). The purpose of steps 503, 507, 517 and 519 is to revisit the achieved target value from the first pass of optimization (the achieved target value already meets the reference target from the first pass) so that the achieved target value reaches its lowest possible value (step 517) (i.e., make the achieved target value more suitable for the relaxation value to be applied to obtain a more suitable second relaxation target value).

[0287] At step 519, the constraint is set to the achieved target value from step 517, which is relaxed by the second relaxation value. In other words, the second relaxation value is applied to the achieved target value to obtain the second relaxed target. The second relaxed target is used as a constraint in subsequent steps. The method then proceeds to step 521, where the next target is considered.

[0288] In step 523, steps 503 to 521 are repeated for all targets. Thus, for each target, a second pass of optimization is performed, and second pass constraints for subsequent steps are obtained.

[0289] At step 525, the second optimization pass is completed.

[0290] Figure 7 A block diagram of an implementation of a radiation therapy system 600 is illustrated. The radiation therapy system 600 includes a computing system 610 within which a set of instructions for causing the computing system 610 to perform any one or more of the methods discussed herein may be executed. The computing system 610 may implement a treatment planning system. The computing system 610 may also be referred to as a computer. The treatment planning system 610 may perform any of the methods described herein. In particular, the methods described herein may be implemented by a processor 611 of the treatment planning system 610.

[0291] Computing system 610 should be considered to include any number of machines or machine collections, such as one or more computing devices, which individually or jointly execute one or more instruction sets to perform any one or more methods discussed herein. That is, hardware and / or software can be provided in a single computing device, or distributed on multiple computing devices in a computing system. In some implementations, one or more elements of a computing system can be connected (e.g., networked) to other machines in, for example, a local area network (LAN), an intranet, an extranet, or the Internet. One or more elements of a computing system can operate with the ability of a server or client machine in a client-server network environment, or operate as a peer machine in a peer-to-peer (or distributed) network environment. One or more elements of a computing system can be a personal computer (PC), a tablet computer, a set-top box (STB), a personal digital assistant (PDA), a cellular phone, a network appliance, a server, a network router, a switch or a bridge, or any machine capable of executing a set of instructions (sequential or otherwise), which specifies the action to be taken by the machine.

[0292] The computing system 610 includes a controller circuit 611 and a memory 613 (e.g., a read-only memory (ROM), a flash memory, a dynamic random access memory (DRAM) such as a synchronous DRAM (SDRAM) or a Rambus DRAM (RDRAM), etc.). The memory 613 may include a static memory (e.g., a flash memory, a static random access memory (SRAM), etc.) and / or an auxiliary memory (e.g., a data storage device), which communicate with each other via a bus (not shown).

[0293] Controller circuit 611 represents one or more general-purpose processors, such as microprocessors, central processing units, accelerated processing units, etc. More particularly, controller circuit 611 may include complex instruction set computing (CISC) microprocessors, reduced instruction set computing (RISC) microprocessors, very long instruction words (VLIW) microprocessors, processors implementing other instruction sets, or processors implementing a combination of instruction sets. Controller circuit 611 may also include one or more special processing devices, such as application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), digital signal processors (DSPs), network processors, etc. One or more processors of the controller circuit may have a multi-core design. Controller circuit 611 is configured to execute processing logic for executing the operations and steps discussed herein.

[0294] The computing system 610 may also include a network interface circuit 618. The computing system 610 may be communicatively coupled to an input device 620 and / or an output device 630 via an input / output circuit 617. In some embodiments, the input device 620 and / or the output device 630 may be an element of the computing system 610. The input device 620 may include an alphanumeric input device (e.g., a keyboard or a touch screen), a cursor control device (e.g., a mouse or a touch screen), an audio device such as a microphone, and / or a tactile input device. The output device 630 may include an audio device such as a speaker, a video display unit (e.g., a liquid crystal display (LCD) or a cathode ray tube (CRT)), and / or a tactile output device. In some embodiments, the input device 620 and the output device 630 may be provided as a single device or separate devices.

[0295] In some embodiments, the computing system 610 may include an image processing circuit 619. The image processing circuit 619 may be configured to process image data 680 (e.g., images or imaging data), such as medical images obtained from one or more imaging data sources, treatment devices 650, and / or image acquisition devices 640. The image processing circuit 619 may be configured to process or pre-process the image data. For example, the image processing circuit 619 may convert the received image data into a specific format, size, resolution, etc. In some embodiments, the image processing circuit 619 may be combined with the controller circuit 611.

[0296] In some embodiments, the radiation therapy system 600 may further include an image acquisition device 640 and / or a treatment device 650, such as described herein. Figure 8 The device disclosed in the example of . The image acquisition device 640 and the treatment device 650 can be provided as a single device. In some embodiments, the treatment device 650 is configured to perform imaging, for example in addition to providing treatment and / or during treatment. The treatment device 650 includes the main radiation delivery components of the radiation treatment system, such as the beam shaping device 850.

[0297] The image acquisition device 640 may be configured to perform positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), single positron emission computed tomography (SPECT), X-ray, and the like.

[0298] Image acquisition device 640 may be configured to output image data 680 that may be accessed by computing system 610. Treatment device 650 may be configured to output treatment data 660 that may be accessed by computing system 610.

[0299] The computing system 610 may be configured to access or obtain treatment data 660, planning data 670, and / or image data 680. The treatment data 660 may be obtained from an internal data source (e.g., from the memory 613) or from an external data source (e.g., the treatment device 650 or an external database). The planning data 670 may be obtained from the memory 613 and / or from an external source such as a planning database. The planning data 670 may include information obtained from one or more of the image acquisition device 640 and the treatment device 650.

[0300] The above methods may be implemented by a computer program. The computer program may include computer code (eg, instructions) 710, which is arranged to instruct a computer to perform the functions of one or more of the above methods. Figure 2 , Figure 3 , Figure 4 , Figure 5 and Figure 6 The steps of the method described above may be performed by computer code 710. The steps of the method described above may be performed in any suitable order. Figure 8The computer program and / or code 710 for performing this method is provided to a device such as a computer on one or more computer readable media described in or more generally on a computer program product 700. The computer readable medium may be transient or non-transient. The one or more computer readable media 700 may be, for example, an electronic, magnetic, optical, electromagnetic, infrared or semiconductor system, or a propagation medium for data transmission (e.g., for downloading code via the Internet). Alternatively, the one or more computer readable media may take the form of one or more physical computer readable media, such as semiconductor or solid-state memory, magnetic tape, removable computer disk, random access memory (RAM), read-only memory (ROM), hard disk and optical disk (e.g., CD-ROM, CD-R / W or DVD). The instructions 710 may also reside completely or at least partially in the memory 613 and / or in the controller circuit 611 during its execution by the computer system 610, the memory 613 and the controller circuit 611 also constituting computer readable storage media.

[0301] In implementation, the modules, components, and other features described herein may be implemented as discrete components, or integrated into the functionality of hardware components such as ASICs, FPGAs, DSPs, or similar devices.

[0302] A "hardware component" is a tangible (e.g., non-transient) physical component (e.g., a set of one or more processors) that is capable of performing certain operations and may be configured or arranged in some physical manner. A hardware component may include dedicated circuitry or logic that is permanently configured to perform certain operations. A hardware component may include a dedicated processor, such as an FPGA or ASIC. A hardware component may also include programmable logic or circuitry that is temporarily configured by software to perform certain operations.

[0303] In addition, modules and components can be implemented as firmware or functional circuits within hardware devices. Further, modules and components can be implemented in any combination of hardware devices and software components, or only in software (e.g., code stored or otherwise embodied in a machine-readable medium or transmission medium).

[0304] Fig. 9 A radiotherapy apparatus according to the invention is described. Fig. 9 A cross section of a radiotherapy apparatus 800 is shown including a radiation head 804 and a beam receiving device 806, both of which are attached to a gantry 802. The radiation head 804 includes a radiation source 807 that emits a radiation beam 822. The radiation head 804 also includes a beam shaping device 850 that controls the size and shape of the radiation field associated with the beam.

[0305] The beam receiving device 806 is configured to receive radiation emitted from the radiation head 804 in order to absorb and / or measure the radiation beam. Figure 8 In the view shown, the radiation head 804 and the beam receiving device 806 are positioned diametrically opposite each other.

[0306] The gantry 802 is rotatable and supports the radiation head 804 and the beam receiving device 806 so that they can rotate about an axis of rotation 805, which can coincide with the longitudinal axis of the patient. Fig. 9 As shown, the gantry provides rotation of the radiation head 804 and the beam receiving device 806 in a plane perpendicular to the longitudinal axis of the patient (e.g., the sagittal plane). Three gantry directions XG, YG, and ZG can be defined, wherein the YG direction is perpendicular to the gantry rotation axis. The ZG direction extends from a point on the gantry corresponding to the radiation head toward the gantry rotation axis. Therefore, from the patient reference system, the ZG direction rotates as the gantry rotates.

[0307] Fig. 9 Also shown is a support surface 810 on which a subject (or patient) is supported during radiation therapy. The radiation head 804 is configured to rotate about a rotation axis 805 so that the radiation head 804 directs radiation to the subject from various angles around the subject so as to spread the radiation dose received by healthy tissue to a larger area of ​​healthy tissue while accumulating a prescribed radiation dose at the target area.

[0308] The radiation therapy apparatus 800 is configured to deliver a radiation beam towards a radiation isocenter that is approximately located on a rotation axis 805 at the center of the gantry 802 , regardless of the angle at which the radiation head 804 is placed.

[0309] The rotatable gantry 802 and radiation head 804 are sized to allow for a central aperture 880. Central aperture 880 provides an opening sufficient to allow a subject to be positioned therethrough without being accidentally contacted by the radiation head 804 or other mechanical components as the gantry rotates the radiation head 804 about the subject.

[0310] like Fig. 9 As shown, the radiation head 804 emits a radiation beam 822 along a beam axis 890 (or radiation axis or beam path), wherein the beam axis 890 is used to define the direction in which the radiation head emits radiation. The radiation beam 822 is incident on a beam receiving device 806, which may include at least one of a beam stopper and a radiation detector. The beam receiving device 806 is attached to the gantry 802 on a side diametrically opposite to the radiation head 804 to attenuate and / or detect the radiation beam after the beam passes through the subject.

[0311] For example, radiation beam axis 890 may be defined as the center or point of maximum intensity of radiation beam 822 .

[0312] The beam shaper 850 defines the spread of the radiation beam 822. The beam shaper 850 is configured to adjust the shape and / or size of the radiation field generated by the radiation source. The beam shaper 850 achieves this by defining a variable shaped aperture (also referred to as a window or opening) to calibrate the radiation beam 822 to a selected cross-sectional shape. In this example, the beam shaper 850 may be provided by a combination of an aperture and a multi-leaf collimator (MLC). The beam shaper 850 may also be referred to as a beam modifier.

[0313] The radiation therapy device 800 can be configured to perform radiation therapy in coplanar and non-coplanar (also called tilted) modes. In coplanar therapy, radiation is emitted in a plane that is perpendicular to the axis of rotation of the radiation head 804. In non-coplanar therapy, radiation is emitted at an angle that is not perpendicular to the axis of rotation. To perform coplanar and non-coplanar therapy, the radiation head 804 can be moved between at least two positions, one in which radiation is emitted in a plane that is perpendicular to the axis of rotation (coplanar configuration) and one in which radiation is emitted in a plane that is not perpendicular to the axis of rotation (non-coplanar configuration).

[0314] In a coplanar configuration, the radiation head is positioned to rotate about an axis of rotation and in a first plane. In a non-coplanar configuration, the radiation head is tilted relative to the first plane so that the radiation field generated by the radiation head is directed at an oblique angle relative to the first plane and the axis of rotation. In a non-coplanar configuration, the radiation head is positioned to rotate in a respective second plane parallel to and displaced from the first plane. The radiation beam is emitted at an oblique angle relative to the second plane so that the beam sweeps out a cone when the radiation head rotates.

[0315] When the radiotherapy apparatus is in coplanar mode and non-coplanar mode, the beam receiving device 806 remains in the same position relative to the rotatable gantry. Therefore, the beam receiving device 806 is configured to rotate about the rotation axis in the same plane in both coplanar mode and non-coplanar mode. This can be the same plane as the plane in which the radiation head rotates.

[0316] The beam shaping device 850 is configured to reduce the spread of the radiation field in a non-coplanar configuration compared to a coplanar configuration.

[0317] Radiation therapy apparatus 800 includes a controller 840 programmed to control radiation source 807, beam receiving device 806, and gantry 802. Controller 840 may perform functions or operations such as treatment planning, treatment delivery, image acquisition, image processing, motion tracking, motion management, and / or other tasks involved in a radiation therapy procedure.

[0318] The controller 840 is programmed to control features of the apparatus 800 in accordance with a radiation therapy plan in order to irradiate a target area of ​​the patient, also referred to as target tissue. The treatment plan includes information about a specific dose to be applied to the target tissue as well as other parameters such as beam angles, dose histogram volume information, the number of radiation beams to be used during treatment, the dose of each beam, etc. The controller 840 is programmed to control various components of the apparatus 800, such as the gantry 802, the radiation head 804, the beam receiving device 806, and the support surface 810, in accordance with the treatment plan.

[0319] The hardware components of the controller 840 may include one or more computers (e.g., general-purpose computers, workstations, servers, terminals, portable / mobile devices, etc.); processors (e.g., central processing units (CPUs), graphics processing units (GPUs), microprocessors, digital signal processors (DSPs), field programmable gate arrays (FPGAs), dedicated or specially designed processors, etc.); memory / storage devices, such as memory (e.g., read-only memory (ROM), random access memory (RAM), flash memory, hard disk drives, optical disks, solid-state drives (SSDs), etc.); input devices (e.g., keyboards, mice, touch screens, MICS, buttons, knobs, trackballs, joysticks, handles, joysticks, etc.); output devices (e.g., displays, printers, speakers, vibration devices, etc.); circuits; printed circuit boards (PCBs); or other suitable hardware. The software components of the controller 140 may include operating device software, application software, etc.

[0320] The radiation head 804 may be connected to a head actuator 830 that is configured to actuate the radiation head 804, for example, between a coplanar configuration and one or more non-coplanar configurations. This may involve translation and rotation of the radiation head 804 relative to the gantry. In some implementations, the head actuator may include a curved track along which the radiation head 804 may move to adjust the position and angle of the radiation head 804. The controller 840 may control the configuration of the radiation head 804 via the head actuator 830.

[0321] The beam shaping device 850 includes a shaping actuator 832. The shaping actuator is configured to control the position of one or more elements in the beam shaping device 850 so as to shape the radiation beam 822. In some implementations, the beam shaping device 850 includes an MLC, and the shaping actuator 832 includes a means for actuating leaves of the MLC. The beam shaping device 850 may also include an aperture, and the shaping actuator 832 may include a means for actuating a block of the aperture. The controller 840 may control the beam shaping device 850 via the shaping actuator 832.

[0322] The treatment plan may include positioning information of the beam shaping device 850. The positioning information of the beam shaping device 850 may include information indicating the configuration of one or more elements of the beam shaping device 850, such as the configuration of leaves of the MLC of the beam shaping device 850, the configuration of the aperture of the beam shaping device 850, the configuration of an opening (e.g., a window or aperture) of the MLC, etc.

[0323] Additional Notes

[0324] As described herein, the goal of the optimizer (or optimization process) is to find an optimized parameter set that minimizes the cost function. However, it will be understood that alternatively and equivalently, the goal of the optimizer (or optimization process) can be to find an optimized parameter set that maximizes the reward function.

[0325] Unless specifically stated otherwise, as will be apparent from the following discussion, it should be understood that throughout the specification, discussions utilizing terms such as "receiving," "determining," "comparing," "implementing," "maintaining," "identifying," "obtaining," "accessing," etc. refer to the actions and processes of a computer system or similar electronic computing device that manipulates data represented as physical (electronic) quantities within the computer system's registers and memories and transforms it into other data similarly represented as physical quantities within the computer system memories or registers or other such information storage, transmission, or display devices.

[0326] Although certain embodiments have been described, these embodiments are presented by way of example only and are not intended to limit the scope of the invention. In fact, the novel methods and devices described herein can be embodied in various other forms; in addition, various omissions, substitutions, and changes can be made to the forms of the methods and devices described herein.

[0327] Example

[0328] Aspects and features of the invention are set out in the following numbered clauses.

[0329] Clause 1A. A method for delivering radiation therapy using a radiation therapy system, the method comprising:

[0330] receiving a reference target, the reference target representing a target to be achieved by the radiation therapy system;

[0331] Performing a first optimization pass to determine a set of parameters based on the received reference target, the set of parameters relating to characteristics of radiation to be delivered by the radiation therapy system, wherein performing the first optimization pass comprises:

[0332] Optimize the parameter set to obtain the first pass achieved value;

[0333] In response to the first-pass achieved value not satisfying the reference target, obtaining a first-pass relaxed target using the first-pass achieved value and the first-pass relaxed value; and

[0334] The configuration of the radiation therapy system is determined using the optimized parameter set and the first pass relaxation target.

[0335] Clause 2A. The method of clause 1A, further comprising:

[0336] In response to the first pass achieving values ​​satisfying the reference target, a configuration of the radiation therapy system is determined using the optimized set of parameters and the reference target.

[0337] Clause 1B. A method for radiation therapy planning for delivering radiation therapy via a radiation therapy system, the method comprising:

[0338] receiving a reference target, the reference target representing a target to be achieved by the radiation therapy system;

[0339] performing an optimization process to determine a set of parameters based on the received reference target, the set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system, wherein the optimization process comprises:

[0340] optimizing the parameter set to obtain the achieved value; and

[0341] In response to the achieved value not satisfying the reference target, obtaining a relaxed target using the achieved value and the relaxed value; and

[0342] The configuration of the radiation therapy system is determined using the optimized parameter set along with the relaxation target.

[0343] Clause 2B. The method according to clause 1B, further comprising:

[0344] In response to the first pass achieving values ​​satisfying the reference target, a configuration of the radiation therapy system is determined using the optimized set of parameters and the reference target.

[0345] Clause 3B. The method of clause 1B or 2B, wherein performing the optimization process comprises:

[0346] Perform the first pass of optimization, which includes:

[0347] Optimizing the parameter set to obtain a first pass achieved value; and

[0348] In response to the first-pass achieved value not satisfying the reference target, obtaining a first-pass relaxed target using the first-pass achieved value and the first-pass relaxed value; and

[0349] The configuration of the radiation therapy system is determined using the optimized parameter set and the first pass relaxation target.

[0350] Clause 3. The method of clause 1A, 2A, 1B, or 2B, wherein determining a configuration of the radiation therapy system using the optimized set of parameters and the first pass relaxation target comprises:

[0351] Additional optimization passes are performed using the relaxed objective or the first-pass relaxed objective as an objective or constraint.

[0352] Clause 4. A method according to clause 1A, 1B or clause 3, when subject to clause 1A or 1B, further comprising:

[0353] Perform the second pass of optimization. The second pass of optimization includes:

[0354] In response to the first-pass realized value satisfying the reference target, further optimizing the parameter set according to the received reference target to obtain a second-pass realized value; and

[0355] Obtaining a second-pass relaxation target using the second-pass realization value and the second-pass relaxation value; and

[0356] The configuration of the radiation therapy system is determined using the further optimized parameter sets and a second pass of the relaxed objectives.

[0357] Clause 5. The method of clause 4, wherein determining the configuration of the radiation therapy system using the further optimized parameter set and the second pass relaxation target comprises:

[0358] An optimization process is performed using the second relaxed treatment plan objective as a goal or constraint.

[0359] Clause 6. The method of any preceding clause, wherein the set of parameters relates to a fluence pattern of radiation to be delivered.

[0360] Clause 7. The method of clause 6, wherein the set of parameters comprises weights of the sub-bundles.

[0361] Clause 8. The method of any of the preceding clauses, wherein determining the configuration of the radiation therapy system comprises determining an arrangement of a beam shaping device.

[0362] Clause 9. The method of clause 8, wherein the beam shaping device is a multi-leaf collimator (MLC).

[0363] Clause 10. The method of any of the preceding clauses, wherein the first pass relaxation value and / or the second pass relaxation value is automatically set according to a cost function.

[0364] Clause 11. The method according to any of the preceding clauses, wherein the reference target comprises any of a cost function, a reference dose and / or a reference volume.

[0365] Clause 12. The method of clause 11, wherein, when the reference target comprises a reference dose, the cost function comprises any one of the following functions: a maximum dose cost function, an average dose cost function, a continuous cost function, and / or an equivalent uniform dose (EUD) cost function.

[0366] Clause 13. The method of clause 11, wherein, when the reference target comprises a reference volume, the cost function comprises any of the following functions: a dose volume histogram (DVH) based cost function, a target penalty cost function, or a parallel cost function.

[0367] Clause 14. The method according to any of the preceding clauses, wherein the reference target relates to any one or more of the following targets: a region of interest, a shell, a planning target volume (PTV), a critical structure, and an organ at risk.

[0368] Clause 15. The method of any of the preceding clauses, wherein the first / second pass relaxation value is obtained relative to the first / second pass realization value and is further bounded by a lower limit value and an upper limit value.

[0369] Clause 16. The method of any of the preceding clauses, wherein the second relaxation value is less than the first relaxation value.

[0370] Clause 17. The method of clause 16, wherein the second relaxation value is between 25% and 75% of the first relaxation value.

[0371] Clause 18. A method for delivering radiation therapy using a radiation therapy system, the method comprising:

[0372] receiving a first reference target and a second reference target, each reference target representing a target to be achieved by the radiation therapy system;

[0373] For each reference target, sequentially optimizing the parameter sets according to any of the preceding clauses; and

[0374] The configuration of the radiation therapy system is determined using the sequentially optimized parameter sets and the first reference target and the second reference target.

[0375] Clause 19. A method for delivering radiation therapy using a radiation therapy system, the method comprising:

[0376] receiving a first reference target and a second reference target, each reference target representing a target to be achieved by the radiation therapy system;

[0377] Performing a first optimization pass to determine a set of parameters according to the first reference target and the second reference target, the set of parameters relating to characteristics of radiation to be delivered by the radiation therapy system, wherein performing the first optimization pass comprises:

[0378] Optimizing the parameter set based on the first reference target to obtain a first pass realization value;

[0379] In response to the first pass realization value not satisfying the first reference target:

[0380] Obtaining a first-pass relaxation target using the first-pass realization value and the first-pass relaxation value; and

[0381] optimizing the parameter set based on the second reference objective and using the first-pass relaxed objective as a constraint to obtain additional first-pass achieved values,

[0382] Performing a second optimization pass according to the first reference target and the second reference target to determine a parameter set for further optimization, wherein performing the second optimization pass includes:

[0383] Responsive to the additional first-pass realization value satisfying the second reference target:

[0384] optimizing the parameter set based on the second reference objective to obtain another second-pass achieved value; and

[0385] Obtaining an additional second-pass relaxed target using the additional second-pass achieved value and the second-pass relaxed value; and

[0386] A configuration of the radiation therapy system is determined using at least the further optimized parameter set, the first-pass relaxation target, and an additional second-pass relaxation target.

[0387] Clause 20. A method for delivering radiation therapy using a radiation therapy system, the method comprising:

[0388] receiving a first reference target and a second reference target, each reference target representing a target to be achieved by the radiation therapy system;

[0389] Performing a first optimization pass to determine a set of parameters according to the first reference target and the second reference target, the set of parameters relating to characteristics of radiation to be delivered by the radiation therapy system, wherein performing the first optimization pass comprises:

[0390] Optimizing the parameter set based on the first reference target to obtain a first pass realization value;

[0391] Responsive to the first pass achieving that the value satisfies the first reference goal:

[0392] optimizing the parameter set based on the second reference target using the first reference target as a constraint to obtain additional first-pass realization values;

[0393] A second optimization pass is performed according to the first reference target and the second reference target to determine a further optimized parameter set, wherein:

[0394] Performing the second pass of optimization involves:

[0395] Responsive to the first pass achieving that the value satisfies the first reference goal:

[0396] Optimizing the parameter set based on the first reference target to obtain a second pass realization value; and

[0397] Obtaining a second-pass relaxation target using the second-pass realization value and the second-pass relaxation value; and

[0398] A configuration of the radiation therapy system is determined using at least the further optimized parameter set and a second pass of the relaxed objectives.

[0399] Clause 21. A treatment planning system for delivering radiation therapy via a radiation therapy device, the treatment planning system comprising a processor configured to:

[0400] receiving a reference target, the reference target representing a target to be achieved by the radiation therapy system;

[0401] Performing a first optimization pass to determine a set of parameters based on the received reference target, the set of parameters relating to characteristics of radiation to be delivered by the radiation therapy system, wherein performing the first optimization pass comprises:

[0402] Optimize the parameter set to obtain the first pass achieved value;

[0403] In response to the first-pass achieved value not satisfying the reference target, obtaining a first-pass relaxed target using the first-pass achieved value and the first-pass relaxed value; and

[0404] The configuration of the radiation therapy system is determined using the optimized parameter set and the first pass relaxation target.

[0405] Clause 22. The treatment planning system of clause 21, wherein the processor is configured to perform any of the above methods.

[0406] Clause 23. A computer-readable medium comprising computer-executable instructions configured to cause a processor to perform any of the above methods.

[0407] Clause 24. The method according to any of the preceding clauses, wherein the method is a method for radiation therapy planning for radiation therapy performed by a radiation therapy system.

Claims

1. A method for radiotherapy planning for radiotherapy by a radiotherapy system, the method comprising: receiving a reference target, the reference target representing a target to be achieved by the radiation therapy system; performing an optimization process according to the received reference target to determine a set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system, wherein the optimization process comprises: optimizing the set of parameters to obtain a realized value; In response to the achieved value not satisfying the reference target, obtaining a relaxed target using the achieved value and a relaxed value; and A configuration of the radiation therapy system is determined using the optimized set of parameters and the relaxation target.

2. The method according to claim 1, characterized in that Also includes: In response to the achieved value satisfying the reference target, a configuration of the radiation therapy system is determined using the optimized parameter set and the reference target.

3. The method according to claim 1, characterized in that Executing the optimization process includes: Perform a first optimization pass, the first optimization pass comprising: optimizing the parameter set to obtain a first pass realization value; In response to the first-pass realization value not satisfying the reference target, obtaining a first-pass relaxation target using the first-pass realization value and a first-pass relaxation value; and A configuration of the radiation therapy system is determined using the optimized set of parameters and the first-pass relaxation target.

4. The method according to claim 3, characterized in that Executing the optimization process also includes: Perform a second optimization pass, the second optimization pass comprising: In response to the first-pass realization value satisfying the reference target, further optimizing the parameter set according to the received reference target to obtain a second-pass realization value; Obtaining a second-pass relaxation treatment plan target using the second-pass realization value and the second-pass relaxation value; and A configuration of the radiation therapy system is determined using the further optimized set of parameters and the second-pass relaxed treatment planning objectives.

5. The method according to claim 4, characterized in that Determining a configuration of the radiation therapy system using the further optimized parameter set and the second-pass relaxed treatment planning goal includes: A further optimization process is performed using the second pass relaxed treatment plan objective as a goal or constraint.

6. The method according to claim 1, characterized in that The parameter set relates to the fluence pattern of radiation to be delivered.

7. The method according to claim 6, characterized in that The set of parameters includes weights for the beamlets.

8. The method according to claim 1, characterized in that Determining the configuration of the radiation therapy system includes determining an arrangement of a beam shaping device.

9. The method according to claim 8, characterized in that The beam shaping device is a multi-leaf collimator (MLC).

10. The method according to claim 1, characterized in that The relaxation value is automatically set according to the cost function.

11. The method according to claim 1, characterized in that: The reference target includes any one of a cost function, a reference dose, and / or a reference volume.

12. The method according to claim 11, characterized in that When the reference target comprises a reference dose, the cost function comprises any one of the following functions: a maximum dose cost function, an average dose cost function, a continuous cost function and / or an equivalent uniform dose (EUD) cost function.

13. The method according to claim 11, characterized in that When the reference target comprises a reference volume, the cost function comprises any of the following functions: a dose volume histogram (DVH) based cost function, a target penalty cost function, or a parallel cost function.

14. The method according to claim 1, characterized in that The reference targets relate to any one or more of the following: a region of interest, a shell, a planning target volume (PTV), a critical structure, and an organ at risk.

15. The method according to claim 1, characterized in that The relaxation value is determined relative to the implementation value and is further bounded by a lower limit value and an upper limit value.

16. The method according to claim 4, characterized in that The second-pass relaxation value is smaller than the first-pass relaxation value.

17. A method for radiation therapy planning for radiation therapy by a radiation therapy system, the method comprising: receiving a reference target and a further reference target, wherein the reference target and the further reference target represent targets to be achieved by the radiation therapy system; Performing a first optimization pass according to the reference target and the further reference target to determine a set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system, wherein performing the first optimization pass comprises: Optimizing the parameter set based on the reference target to obtain a first pass realization value; In response to the first pass realization value not satisfying the reference target: Obtaining a first-pass relaxation target using the first-pass realization value and the first-pass relaxation value; and optimizing the set of parameters based on the additional reference objective and using the first-pass relaxed objective as a constraint to obtain additional first-pass realization values; Performing a second optimization pass according to the reference target and the additional reference target to determine a parameter set for further optimization, wherein performing the second optimization pass comprises: Responsive to the additional first-pass realization value satisfying the additional reference target: optimizing the set of parameters based on the additional reference target to obtain additional second-pass realization values; and Obtaining an additional second-pass relaxation target using the additional second-pass realization value and the second-pass relaxation value; and A configuration of the radiation therapy system is determined using at least the further optimized parameter set, the first-pass relaxation target and the additional second-pass relaxation target.

18. A method for implementing a radiation therapy plan for radiation therapy by a radiation therapy system, the method comprising: receiving a reference target and a further reference target, wherein the reference target and the further reference target represent targets to be achieved by the radiation therapy system; Performing a first optimization pass according to the reference target and the further reference target to determine a set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system, wherein performing the first optimization pass comprises: Optimizing the parameter set based on the reference target to obtain a first pass realization value; In response to the first pass achieving a value satisfying the reference target: optimizing the set of parameters based on the additional reference target using the reference target as a constraint to obtain additional first-pass realization values; Performing a second optimization pass according to the reference target and the additional reference target to determine a parameter set for further optimization, wherein performing the second optimization pass comprises: In response to the first pass achieving a value satisfying the reference target: Optimizing the parameter set based on the reference target to obtain a second pass realization value; and Obtaining a second-pass relaxation target using the second-pass realization value and the second-pass relaxation value; and A configuration of the radiation therapy system is determined using at least the further optimized set of parameters and the second pass relaxation target.

19. A treatment planning system for implementing radiation therapy by a radiation therapy device, the treatment planning system comprising a processor, the processor being configured to: receiving a reference target, the reference target representing a target to be achieved by the radiation therapy system; performing an optimization based on the received reference target to determine a set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system, wherein Performing the optimization includes: optimizing the set of parameters to obtain a realized value; In response to the achieved value not satisfying the reference target, obtaining a relaxed target using the achieved value and a relaxed value; and A configuration of the radiation therapy system is determined using the optimized set of parameters and the relaxation target.

20. A non-transitory computer-readable medium comprising computer-executable instructions configured to cause a processor to: receiving a reference target, the reference target representing a target to be achieved by the radiation therapy system; as well as performing an optimization based on the received reference target to determine a set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system, wherein Performing the optimization includes: optimizing the set of parameters to obtain a realized value; In response to the achieved value not satisfying the reference target, obtaining a relaxed target using the achieved value and a relaxed value; as well as A configuration of the radiation therapy system is determined using the optimized set of parameters and the relaxation target.